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CHAPTER 1 
 
INTRODUCTION 
	
Pancreas physiology 
The pancreas is a dual functioning organ with both endocrine and exocrine functions 
(Figure 1.1) that resides in the abdominal cavity adjacent to the stomach. The exocrine 
compartment, comprised of acinar and ductal cells, constitutes the bulk of the pancreatic mass 
and aids in the digestion of food. The acinar cell is the functional unit of the exocrine pancreas 
whose major role is the synthesis, storage, and production of digestive enzymes, which are 
secreted into the small intestine through a system of ducts. Conversely, the endocrine pancreas 
consists of the Islets of Langerhans that function to regulate blood glucose levels. The Islets of 
Langerhans are comprised of five hormone-producing cells: beta, alpha, delta, pancreatic 
polypeptide, and epsilon cells that secrete insulin, glucagon, somatostatin, pancreatic 
polypeptide, and ghrelin, respectively. While the murine islet has a well-defined cellular 
architecture with beta cells positioned in the core and the other endocrine cells positioned at the 
periphery, this spatial distribution is not observed in humans (Bosco et al., 2010).  
 A critical role of the endocrine pancreas is the regulation of plasma glucose levels. Blood 
glucose is tightly regulated by the endocrine hormones insulin and glucagon secreted by the beta 
and alpha cells. In response to elevated glucose, beta cells release insulin to stimulate glucose 
uptake by the adipose and muscle tissue, induce glycogen synthesis, and inhibit gluconeogenesis 
in the liver (Barthel & Schmoll, 2003). Conversely, glucagon is the major counterpart to insulin 
and is released during hypoglycemia to promote hepatic glucose production (Gromada, Franklin, 
& Wollheim, 2007; Shepherd & Kahn, 1999).  
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The exocrine pancreas is responsible for the secretion of digestive enzymes, ions, and 
water into the duodenum. The digestive enzymes are essential for the proper digestion and 
absorption of food across the gastrointestinal surface of the epithelium with loss of exocrine 
function resulting in compromised absorption of nutrients and malnutrition. The secretion of 
water and ions is necessary for the transportation of the digestive enzymes from the pancreatic 
acinar cells to the intestine. Tight junctions between acinar cells prevent the passage of large 
molecules, such as the digestive enzymes, while allowing for the paracellular passage of water 
and ions (Logsdon & Ji, 2013). 
 
Overview of pancreas development 
Pancreas development begins midway through gestation with the evagination of the 
endoderm to form the dorsal and ventral buds, which eventually fuse together (Gittes, 2009; 
Oliver-Krasinski & Stoffers, 2008; Pan & Wright, 2011). These buds are comprised of 
multipotent pancreatic progenitor cells (MPCs) that express many genes, such as Ptf1a, Pdx1, 
Sox9, Hnf6, and Nkx6.1. MPCs give rise to all three lineages of the pancreas (acinar, endocrine, 
and duct) and become committed to the pancreatic fate with the expression of Ptf1a (Kawaguchi 
et al., 2002). Ptf1a expression is maintained in MPCs that give rise to immature acinar cells, 
where it interacts with Rbpj. As acinar cells mature, Rbpjl replaces Rbpj in the trimeric PTF1 
complex, a complex important for the expression of acinar-specific genes (Masui et al., 2010) 
(Holmstrom et al., 2011). MPCs also give rise to Sox9+/ Nkx6.1+ bipotent cells (Arda, Benitez, & 
Kim, 2013), which further differentiate into exocrine ductal cells expressing Sox9 (McDonald et 
al., 2012) or into a transient population of Neurog3 expressing endocrine precursor cells. High 
Neurog3 expressing progenitors give rise to all hormone-secreting endocrine cells of the 
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pancreas. A number of transcription factors are required for beta cell differentiation and 
maturation including Pax4, Nkx2.2, and Pdx1. Beta cell-specific deletion of these factors results 
in a reduction of beta cells. MafA is important for beta cell maturation and activates many genes 
important for its function (Kaneto et al., 2005; Kataoka et al., 2002; H. Wang, Brun, Kataoka, 
Sharma, & Wollheim, 2007; C. Zhang et al., 2005). During development, beta cells proceed from 
a MafB immature state to a MafB intermediate state and finally to a MafA mature state (Artner et 
al., 2007; Artner et al., 2010).   
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Figure 1.1 Human pancreas anatomy. (A) Gross anatomy of the pancreas. (B) Exocrine (left) 
and endocrine (right) pancreas. The exocrine pancreas consists of acinar and ductal cells and aids 
in the digestion of food while the exocrine pancreas is composed of four specialized cell types, 
beta-, alpha-, delta-, and PP-cells, which comprise the Islets of Langerhans and secrete hormones 
into the blood stream to regulate blood glucose levels. Image adapted (Bardeesy & DePinho, 
2002). 
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Diabetes mellitus 
Diabetes mellitus (DM) is an endocrine disorder associated with hyperglycemia and 
results in severe damage to the blood vessels, eyes, kidneys, and heart. According to the latest 
survey, 417 million people worldwide suffer from DM and the number affected is expected to 
grow exponentially in the next few decades with 642 million people worldwide predicted to 
suffer from diabetes in 2040. Diabetes places a huge financial burden on individuals and their 
families, and it also imposes a huge economic burden on countries, with the majority of countries 
spending between 5% and 15% of their total health expenditure on diabetes (P. Zhang et al., 
2010). This chronic disease is categorized into three major types: Type 1 (T1D), Type 2 (T2D), 
and gestational diabetes.  
T1D occurs predominantly in young people and is due to the autoimmune destruction of 
pancreatic beta cells, leading to insulin deficiency. T1D arises in genetically susceptible 
individuals, most likely as a result of an environmental trigger. Genetic data identifies the 
following genes as susceptibility genes: HLA, insulin, PTPN22, IL2Ra, and CTLA4 (van Belle, 
Coppieters, & von Herrath, 2011). There is currently no cure for T1D.  Alternatively, T2D is 
much more common, comprising 90-95% of those diagnosed, and results from both insulin 
resistance and impaired beta cell function (Cavaghan, Ehrmann, & Polonsky, 2000). Risk factors 
for T2D include excess body weight, physical inactivity, poor nutrition, genetics, family history 
of diabetes, and older age. T2D can go undiagnosed for years and can often be managed with 
dietary changes, increased physical activities, and medications. T1D and T2D are polygenic 
disorders, and multiple genes and environmental factors contribute to the development of the 
disease. Gestational diabetes, characterized by slightly elevated blood glucose levels during 
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pregnancy, imposes serious health risk to both the mother and child and is associated with an 
increased risk to both the mother and child in developing T2D later in life.   
 
Current and future treatments for T1D 
T1D is due to the autoimmune-mediated destruction of pancreatic beta cells leading to a 
profound impairment of insulin secretion. A curative therapy for T1D requires both the 
restoration of the lost beta cell mass and amelioration of the autoimmune attack. For nearly the 
past one hundred years, the only effective treatment for T1D has been lifelong insulin therapy. 
However, for many people blood glucose control is inadequate, thereby leading to serious 
complications, including hypoglycemia, nephropathy, retinopathy, and other vasculopathies. 
Over the last few decades, transplantation of whole pancreas and isolated beta cells indicate that 
diabetes can be cured by replenishment of deficient beta cells (Shapiro et al., 2006). These 
promising results, paired with the shortage of cadaver pancreases, have lent strong motivation to 
the search for new sources of beta cells. Strategies to produce beta cells suitable for 
transplantation include expansion of existing beta cells, directed differentiation of embryonic 
stem cells to beta cells, and reprogramming of other terminally differentiated cells into beta cells 
(Figure 1.2) (Bonner-Weir & Weir, 2005; Pagliuca & Melton, 2013). 
A potential source of new beta cells is through expansion of existing beta cells, which, if 
achieved, offer an autologous source of new beta cells capable of regulating blood glucose. 
While young beta cells have relatively high replication rates, adult beta cells have very low 
replication rates (Teta, Long, Wartschow, Rankin, & Kushner, 2005). However, the expansion of 
adult beta cells mass increases during pregnancy and obesity (Nichols, New, & Annes, 2014), 
and a landmark study demonstrated that pre-existing beta cells, rather than stem cells, are the 
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major source of new beta cells during adult life and after pancreatectomy in mice (Dor, Brown, 
Martinez, & Melton, 2004). This observation has led to a profound interest in defining 
pharmacologic approaches to therapeutically control beta cell growth and mass. While the 
therapeutic potential of harnessing the latent growth potential of mature beta cells for the 
treatment of diabetes exists, at present, a clinically viable strategy does not exist. 
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Figure 1.2 Strategies for creating new beta cells. Three strategies to generate new beta cells 
include (A) directed differentiation of induced pluripotent stem cells (iPSCs), (B) replication of 
existing beta cells, and (C) reprogramming or mature cells types into new beta cells. Image 
adapted (Pagliuca & Melton, 2013).	
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Cellular reprogramming overview 
 Cellular reprogramming, defined as the process in which a differentiated cell is changed 
into that of another state (Halley-Stott, Pasque, & Gurdon, 2013), holds great promise for 
regenerative medicine. The ultimate goal of regenerative medicine is to replace damaged cells. 
This can potentially be accomplished through the different avenues of cellular reprogramming: 
dedifferentiation followed by directed differentiation or transdifferentiation. Indeed, the forced 
overexpression of key transcription factors has been shown to convert fully differentiated cells 
into pluripotent stem cells (dedifferentiation), convert pluripotent cells into fully differentiated 
cells (directed differentiation) and can also induce fully differentiated cells to convert into 
another mature cell type (transdifferentiation).  
 The first instance of experimentally induced cellular reprogramming was in 1962 when 
Sir John Gurdon reported cellular reprogramming through somatic cell nuclear transfer (SCNT) 
(Gurdon, 1962). SCNT involves transferring the nucleus of a mature cell into an enucleated egg 
resulting in the production of an embryo that is a clone of the donor somatic cell. This work 
demonstrated the feasibility of experimentally manipulating a cell’s identity. However, the field 
of cellular reprogramming experienced limited progress following Gurdon’s work. It wasn’t until 
the late 20th century that several groups expanded the field of cellular reprogramming, reporting 
the direct cell fate conversion (transdifferentiation) through the introduction of a single factor. 
Indeed, it was shown that the forced overexpression of MYOD converts fibroblasts into myoblast 
followed by the finding that the forced expression of the GATA 1 reprograms myeloblasts into 
eosinophils (J. Choi et al., 1990; Kulessa, Frampton, & Graf, 1995). However, it was the seminal 
discovery of induced pluripotent stem cells (iPSCs) that has paved the way for cell fate 
conversion studies in which the overexpression of a set of defined transcription factors can 
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induce the conversion of cell fates. In a groundbreaking study, Yamanaka demonstrated that viral 
transfection of four transcription factors, Oct4, Sox2, Klf4, and Myc (OSKM), reprograms 
somatic cells into iPSCs. These cells are then capable of being reprogrammed into any cell type 
(Takahashi & Yamanaka, 2006). 
 Although OSKM converts somatic cells into iPSCs, the reprogramming efficiency is low 
and the reprogramming is a stochastic event often leading to only partially reprogrammed iPSCs 
(Takahashi & Yamanaka, 2006, 2016). Thus, researchers have attempted to refine the 
reprogramming protocol and identify reprogramming enhancers to overcome these limitations. 
Such studies have reported that the addition of other pluripotency-associated genes, such as 
TBX3, can enhance the reprogramming efficiency. Furthermore, the addition of certain 
microRNAs, including miR-291-3p, miR-294, and MIR-295, has been shown to enhance OSK 
reprogramming (Han et al., 2010; Judson, Babiarz, Venere, & Blelloch, 2009).  Furthermore, 
studies have also identified the transcriptional and epigenetic changes involved in the 
reprogramming of a somatic cell into an iPSC. Gene expression profiling at defined points 
during reprogramming has revealed three stages of reprogramming: initiation, maturation, and 
stabilization (Samavarchi-Tehrani et al., 2010). The initiation phase is marked by an increase in 
proliferation, histone modifications, mesenchymal-to-epithelial transition, and activation of DNA 
repair and RNA processing. In the intermediate stage, reprogrammed cells undergo activation of 
pluripotency markers, developmental regulators, and glycolysis. In the final stage, the cells 
establish a pluripotent signature independent of transgenes expression (Buganim, Faddah, & 
Jaenisch, 2013; David & Polo, 2014). Studies have also revealed that Oct4, Sox2, and Klf4 
function as “pioneer factors” binding to inaccessible chromatin regions, while MYC enhances 
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the binding of pluripotency markers to the chromatin leading to chromatin remodeling and 
activation of repressed genes (Soufi, Donahue, & Zaret, 2012). 
 The ability to modulate cell identity and the knowledge gained from dedifferentiation 
studies have spurred investigators to define transcription factors that allow for cell fate 
conversions without reverting back to the pluripotent state (transdifferentiation). Indeed, the 
generation of iPSCs suggest that, rather than a single factor, a specific combination of 
transcription factors could alter a cell’s identity, allowing for greater cellular plasticity than once 
believed. Furthermore, the ability to obtain a desired, differentiated cell-type would allow for 
studies on disease modeling, regenerative medicine, and drug interactions. Thus, researchers 
have identified transcription factors that allows for the conversion of pancreatic acinar cells into 
insulin-secreting beta cells, fibroblast into neurons, and fibroblast into cardiomyocytes (Ieda et 
al., 2010; Vierbuchen et al., 2010; Zhou, Brown, Kanarek, Rajagopal, & Melton, 2008). In 
addition, databases, such as CellNet, have been developed allowing researchers to assess the 
fidelity of cellular reprogramming in order to determine the degree to which the reprogrammed 
cell resembles the corresponding target cell in molecular and functional terms (Cahan et al., 
2014).  
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Figure 1.3 Routes of cellular reprogramming. A cell’s identity is defined by its epigenetic and 
transcriptional landscape. Once believed to be immutable, a number of experimental 
manipulations can alter a cell’s identity resulting in cellular reprogramming. Processes include 
dedifferentiation, directed differentiation, and transdifferentiation. Image adapted (Cherry & 
Daley, 2012).	
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Cellular reprogramming as a therapy for Type 1 diabetes 
Until recently, cellular identities were thought to be largely immutable. However, in 2006 
Yamanaka converted fibroblasts into iPSCs by the introduction of four different transcription 
factors (Takahashi & Yamanaka, 2006). The ability to perform cellular reprogramming has 
opened a new paradigm for regenerative medicine in which specific cell types can be obtained by 
reprogramming other cell types. These advances may enable a truly curative therapy for T1D.  
iPSCs have the potential to differentiate into any somatic cell, making them ideal 
candidates for cell replacement therapies. Towards this goal, much progress has been made in 
developing protocols for the directed differentiation of iPSCs to insulin-producing beta cells. 
These protocols follow a stepwise conversion that closely mimics the development of beta cells, 
differentiating iPSCs cells towards the definitive endoderm, pancreatic endoderm, endocrine 
lineages, and finally to the beta cell. Many of these differentiation protocols derive pancreatic 
progenitors in vitro and then subsequently transplant these progenitors into immunodeficient 
mice to allow them to further develop and mature into functional beta cells (D'Amour et al., 
2006; Kroon et al., 2008; Rezania et al., 2012). Indeed, the majority of protocols that derived 
insulin-expressing cells wholly from in vitro cells did not produce fully mature or functional beta 
cells (Cheng et al., 2012; Hrvatin et al., 2014; Narayanan et al., 2014). However, improved 
protocols were able to generate glucose-responsive insulin-producing cells in vitro that share 
significant similarities with endogenous beta cells (Pagliuca et al., 2014; Rezania et al., 2014). 
While the molecular mechanisms underlying the generation of functional beta cells remain to be 
elucidated, cell-based therapeutics to treat T1D have advanced to the point where the first Phase 
I/II trials in humans have begun.  
An alternative strategy to differentiating iPSCs in a step-wise fashion into beta cells is the 
reprogramming of terminally differentiated cell-types into new, functional beta cells. Indeed, 
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hepatocytes, fibroblasts, intestinal and gastric crypt cells, gallbladder cells, pancreatic alpha 
cells, and pancreatic acinar cells have all been reprogrammed into beta-like cells (Akinci et al., 
2013; Ariyachet et al., 2016; Banga, Akinci, Greder, Dutton, & Slack, 2012; S. X. Chen et al., 
2011; Y. J. Chen et al., 2014; Hickey et al., 2013; Luo et al., 2014; Thorel et al., 2010; Zhou & 
Melton, 2008). The pancreatic acinar cells represent an appealing reprogramming target. They 
are located in the pancreas, are highly abundant, are derived from a common progenitor cell 
during pancreatic organogenesis (Gu, Dubauskaite, & Melton, 2002), and exhibit transcriptional 
plasticity (W. Li, M. Nakanishi, et al., 2014; Puri, Folias, & Hebrok, 2015; Ziv, Glaser, & Dor, 
2013). Indeed, pancreatic acinar cells have been converted into new beta-like cells by cellular 
reprogramming in response to both physiological processes and experimental interventions 
(Baeyens et al., 2013; Zhou et al., 2008). Acinar cells have been successfully converted into 
insulin-expressing beta-like cells by the transient administration of epidermal growth factor and 
ciliary neurotrophic factor (Baeyens et al., 2013). In addition, the adenoviral delivery of Pdx1, 
Neurog3, and MafA (3TF) to the pancreas of immunocompromised Rag1-/- mice has also been 
shown to reprogram pancreatic acinar cells into insulin-expressing beta-like cells (Zhou et al., 
2008). Subsequent reports have shown that these three transcription factors can also reprogram 
hepatocytes, fibroblasts, intestinal crypt cells, and gallbladder cells into new insulin-expressing 
beta-like cells (Akinci et al., 2013; Banga et al., 2012; Y. J. Chen et al., 2014; Hickey et al., 
2013; Luo et al., 2014).  
 
Biological differences between acinar and beta cells 
The effects of acinar to beta cell (A→β) reprogramming on the microscopic anatomy, 
cellular function, and physiological function of the pancreas has not been studied but would be 
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expected to be substantial. Acinar cells, which constitute the bulk of the pancreas, synthesize 
copious amounts of digestive enzymes that they secrete directly into the pancreatic ductal tree 
(Logsdon & Ji, 2013). In contrast, pancreatic beta cells, like other pancreatic endocrine cells, are 
co-located in the Islets of Langerhans where they secrete the hormones they produce into the 
bloodstream (Kulkarni, 2004). These very marked physiological and histological differences 
raise important questions about the consequences of A→β conversion, especially when it 
involves a cell whose function is to produce enzymes for the digestion of proteins, complex 
carbohydrates, lipids, and nucleic acids.  
 
Digestive enzymes 
 Pancreatic acinar cells synthesize and secrete more proteins than any other cell-type 
(Logsdon & Ji, 2013) with the majority being digestive enzymes. The synthesis, storage, and 
secretion of digestive enzymes is influenced by external inputs from nerves and hormones and 
tightly regulated to ensure that the production and delivery of the digestive enzymes matches 
dietary need. The trimeric PTF1-L complex binds to the pancreas consensus element and 
activates the expression of the digestive enzymes such as amylase, chymotrypsin B, 
carboxypeptidase A, and elastase 1 (Boulet, Erwin, & Rutter, 1986; Masui et al., 2008). The 
relative synthesis rate of the specific digestive enzymes changes as a function of the dietary 
intake. A carbohydrate-rich diet increases expression of amylase and decreases 
chymotrypsinogen while a lipid-rich diet enhances lipase expression (Pandol, 2010).  
 Digestive enzymes are stored in zymogen granules at the apical surface of the acinar cell. 
The basolateral membrane of acinar cells contains receptors for neurohumoral agents such as 
gastrin-releasing peptide, secretin, cholecystokinin, acetylcholine, and vasoactive intestinal 
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polypeptide. Activation of these receptors causes changes in intracellular calcium ([Ca2+]i )  or 
cAMP, which in turn mediates exocytosis of the digestive enzymes. 
The enzymes of the pancreas (Table 1.1) are divided into two main groups: the 
endopeptidases and the exopeptidases. The exopeptides hydrolyze the terminal bonds of proteins 
or peptide molecules, whereas the endopeptidases attack the internal peptide bonds (Beck, 1973). 
These digestive enzymes normally become activated when they enter the duodenum. Activation 
occurs at the surface of the duodenal lumen where trypsinogen is activated by enterokinase, a 
glycoprotein peptidase, which through hydrolysis removes an N-terminal hexapeptide fragment 
(Rinderknecht, 1986). The active form of trypsin then catalyzes the activation of the other 
proenzymes. These digestive enzymes, if prematurely activated, are capable of digesting the 
acinar cell and can cause significant damage to the pancreas.  
 
Table 1.1 Digestive enzymes of the pancreas 
Proteolytic enzymes 
Endopeptidases: 
     Trypsin 
     Chymotrypsin 
     Elastase 
Exopeptidases: 
     Carboxypeptidase A 
     Carboxypeptidase B 
Lypolytic enzymes  
Lipase 
Cholesterol esterase 
Phospholipase A 
Amylolytic enzymes  
α-Amylase 
Other enzymes 
Ribonuclease 
Desoxyreibonuclease 
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Pancreatic inflammation and acinar-to-ductal metaplasia 
The exocrine pancreas protects itself from autodigestion by the potent proteases, lipases, 
and ribonucleases it produces through several mechanisms. First, many of the enzymes are 
secreted as inactive pro-enzymes, or zymogens, which only become active within the duodenum 
(Neurath & Walsh, 1976). Second, the proteolytic enzymes are co-secreted with a trypsin 
inhibitor that prevents the premature activation of typsinogen, which normally becomes activated 
in the small intestine and is responsible for the activation of the other precursor digestive 
enzymes (Logsdon & Ji, 2013). Third, acinar-to-ductal metaplasia (ADM) occurs (Bockman, 
Muller, Buchler, Friess, & Beger, 1997; Liou et al., 2013; Pan et al., 2013) and has been 
suggested to limit autodigestion in the face of inflammation or injury (Puri et al., 2015).   
ADM is characterized by the formation of duct-like complexes and fibrosis (R. N. Wang, 
Kloppel, & Bouwens, 1995) and is accompanied by transcriptional changes in acinar cells, most 
notably by expression of cytokeratins (Strobel et al., 2007), Pdx1 (Rooman, Heremans, 
Heimberg, & Bouwens, 2000; Song et al., 1999), and ductal transcription factors Sox9 and 
Onecut1 (Rooman & Real, 2012). However, the precise mechanisms that initiate both pancreatic 
inflammation and ADM remain in dispute. Some have argued that pancreatic inflammation is 
due to intracellular activation of trypsinogen (Halangk et al., 2000; Szilagyi et al., 2001; Van 
Acker et al., 2002; Whitcomb et al., 1996) whereas others have suggested that calcium overload 
(Li, Zhou, Zhang, & Li, 2014) and endoplasmic reticulum (ER) stress (Ji et al., 2003; Logsdon & 
Ji, 2013) are principally responsible.   
 
Pdx1, Neurog3, and MafA mediated acinar to beta cell reprogramming  
A complex series of events must occur in order for an acinar cell to convert into a beta 
cell. Acinar cells must cease zymogen production, delaminate and migrate to the surrounding 
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mesenchyme, then cluster into new vascularized islets. It is vital to gain a clear understanding of 
the cellular dynamics of A→β conversion for an in vivo beta cell restorative therapy to ever be 
clinically feasible. Indeed, much care must be taken to prevent acinar cell damage and pancreatic 
inflammation during A→β reprogramming. Due to the physiological role of acinar cells, whose 
function is to produce digestive enzymes, it is not unfathomable that, if not properly regulated, 
A→β reprogramming could cause pancreatic damage. For one, the complex cellular changes that 
occur during A→β conversion may require substantial time to allow acinar cells to 1) cease the 
production and secretion of tissue-digesting enzymes and 2) establish a new endocrine cell-like 
state of internal homeostasis. If the pace of such events occurs at a rate that exceeds the ability of 
the cell to undergo an orderly transition from one cell state to another, this could lead to cellular 
damage. Indeed, a recent study that used adenoviral delivery of the three transcription factors 
demonstrated that it took two months for the reprogrammed acinar cells to adopt a DNA 
methylation and transcriptional profile similar to that of endogenous beta cells and seven months 
for the reprogramed cells to functionally mimic beta cells (W. Li, C. Cavelti-Weder, et al., 2014). 
Second, pancreatic acinar cells are especially vulnerable to ER dysfunction owing to their high 
level of protein synthetic and secretory activity (Ji et al., 2003; Logsdon & Ji, 2013). It is 
possible that high levels of factor expression could induce ER stress and subesquently pancreatic 
inflammation. In fact, multiple studies have reported acinar cell inflammation or ADM in 
response to ectopic factor overexpression. For instance, the overexpression of either Pdx1, Isl1 or 
Sox9 have all been shown to induce metaplastic pancreatic changes (Kopp et al., 2011; 
Miyatsuka et al., 2006; Miyazaki, Tashiro, Fujikura, Yamato, & Miyazaki, 2012). 
While it is vital to understand the cellular changes associated with A→β reprogramming 
in order to prevent adverse consequences such as pancreatic damage and metaplasia, this does 
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not diminish the important implications that 3TF-mediated A→β reprogramming has for 
advancing the field of regentative medicine and cellular reprogramming. For starters, researchers 
can begin to invesitigate why and how these particular factors (3TF) are able to induce A→β 
conversion when other pancreatic/beta cell specific factors were unable to induce such a 
conversion. To identify transcriptional factors capable of reprogramming acinar cells into beta 
cells, Zhou et al. screened a pool of nine beta cell-associated candidate genes. The combination 
of all nine, when co-expressed from adenoviral vectors, induced a modest conversion of acinar 
cells into beta-like cells. Successive rounds of elimination of individual factors led to the 
identification of the minimally required set of factors comprised of Pdx1, Neurog3, and MafA 
required to achieve the highest level of A→β reprogramming. These reprogrammed cells 
expressed insulin along with beta cell markers including Glut2, PC1/3, NeuroD, Nkx2.2, and 
Nkx6.1 (Zhou et al., 2008).  
Pdx1, Neurog3, and MafA all play critical roles in beta cell development, maturation, and 
function. Pdx1-expressing epithelium gives rise to all three lineages of the pancreas (acinar, 
endocrine and duct) (Gu, Brown, & Melton, 2003) and is required for the embryonic 
development of the pancreas and beta cell function. Homozygous deletion of Pdx1 results in 
pancreatic agenesis (Offield et al., 1996); while Pdx1 haploinsufficiency causes compromised 
beta cell function resulting in impaired glucose tolerance and glucose-stimulated insulin 
secretion (Brissova et al., 2002). Indeed, Pdx1 activates insulin as well as many genes involved 
in insulin biosynthesis and secretion (Khoo et al., 2012). 
Neurog3 is a master regulator required for the MPCs to enter the endocrine lineage.  
Indeed, Neurog3+ cells contribute to all endocrine cells of the mature pancreas (Gradwohl, 
Dierich, LeMeur, & Guillemot, 2000; Gu et al., 2002). Neurog3 is transiently expressed in MPCs 
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and is progressively down regulated as the endocrine program is initiated. Mice deficient for 
Neurog3 fail to generate pancreatic endocrine cells and die postnatally (Gradwohl et al., 2000) 
while Neurog3 haploinsufficiency results in decreased endocrine cell mass (S. Wang et al., 
2010). Direct targets of Neurog3 include genes critical for endocrine differentiation such as 
NeuroD1, Pax4, Insm1, and Nkx2.2 (H. P. Huang et al., 2000; Smith et al., 2003; Watada, 
Scheel, Leung, & German, 2003).  
MafA is vital for beta cell maturation and function with MafA-deficient mice developing 
diabetes as they age (C. Zhang et al., 2005). Furthermore, MafA is crucial for the functional 
maturation process as nascent beta cells acquire glucose-responsive insulin secretion (Aguayo-
Mazzucato et al., 2011). Direct targets of MafA include genes critical for beta cell function, 
including glucose sensing, vesicle maturation, and Ca2+ signaling (H. Wang et al., 2007).  
Indeed, Pdx1, Neurog3, and MafA play important roles in beta cell development, function, and 
maturation. Thus, it is not surprising that in combination these factors are able to induce A→β 
reprogramming. However, much work remains elucidating the cellular and molecular changes 
associated with A→β reprogramming and the role of each factor in the reprogramming process.   
 
Aims of Dissertation 
Over the past decade, efforts have intensified to develop new therapies that will replace 
or regenerate beta cells that have been destroyed by autoimmune attack in people with T1D. 
Among the therapeutic avenues being explored, reprogramming other non-beta pancreatic cell 
types into new beta cells is particularly appealing. If achievable, this approach has the advantage 
that newly generated beta cells would be autologous and would be produced in their natural 
anatomical location, the pancreas. There has been marked progress in achieving this goal with 
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both pancreatic acinar- and alpha-cells being converted into insulin-secreting beta-like cells 
(Baeyens et al., 2014; Thorel et al., 2010; Zhou et al., 2008). Indeed, it has been shown that 
adenoviral delivery of 3TF to the pancreas of immunocompromised mice converts pancreatic 
acinar cells into insulin-secreting beta-like cells (W. Li, C. Cavelti-Weder, et al., 2014; Zhou et 
al., 2008). The primary goal of the research included in this dissertation is to understand the 
factors that promote or inhibit 3TF-mediated A→β reprogramming as well as the physiological 
effects that inducing such a conversion might cause. A better understanding of the cellular 
dynamics of A→β conversion is vital for an in vivo beta cell restorative therapy to ever be 
clinically feasible. 
In order to understand the dynamics of A→β, the Magnuson lab developed and validated 
a novel diallelic transgene-based mouse model that co-expresses 3TF and a fluorescent reporter, 
mCherry, in both an acinar cell- and doxycycline (dox)-dependent manner. The derivation and 
validation of this mouse model is described in Chapter 3.  
Using this mouse model, I discovered that the outcome of transcription factor-mediated 
A→β reprogramming is highly dependent on both the magnitude of 3TF expression and 
reprogramming-induced inflammation. Overly robust 3TF expression causes acinar cell necrosis 
resulting in marked inflammation and ADM. New beta-like cells are observed only when 
reprogramming-induced inflammation is attenuated by either reducing 3TF expression or 
eliminating macrophages. In Chapter 4, the inflammatory response associated with high levels of 
3TF overexpression and the corresponding pancreatic histological changes are characterized.  
In the following chapters, experimental variables that may influence the outcome of 
A→β reprogramming are investigated. Since the reprogramming outcome using transgene-
mediated 3TF expression in Rag1+/+ mice differed so markedly from the use of adenoviral-
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mediated expression in Rag1-/- mice, I examined the role of variables that differ between these 
two experimental designs. Two obvious differences are the use of a transgene to express 3TF, 
opposed to a viral vector, and the presence of Rag1. The role of these variables is investigated in 
Chapter 5. In Chapter 6, I investigate the role of inflammation on influencing the outcome of 
3TF-mediated A→β reprogramming.   
Furthermore, to determine the specific role of the individual factors in A→β 
reprogramming, the Magnuson lab developed mice that express either Pdx1 or Neurog3 in both 
an acinar cell- and dox-dependent manner. In chapter 7, I briefly discuss the derivation and 
characterization of these mice models.  
The materials and methods used to conduct these studies are described in Chapter 2, and 
the overall conclusion and future directions are presented in Chapter 8.  
 
 
 
 
 
 
 
Some material in this dissertation has been published in Worchel & Magnuson, 2014 (Worchel 
& Magnuson, 2014) and Clayton et al., 2016 (Clayton et al., 2016)  
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CHAPTER 2 
 
MATERIALS AND METHODS 
	
Mouse lines and husbandry 
All animals were housed at the Vanderbilt Institutional Animal Care Facility and 
experimental protocols were approved by the Vanderbilt Institutional Animal Care and Use 
Committee. Mice were treated with dox (Sigma) dissolved in a 5% sucrose solution beginning at 
6 to 8 weeks of age. Dox was provided ad libitum in lieu of the normal water supply. 
Rosa26rtTA/+ (Hochedlinger, Yamada, Beard, & Jaenisch, 2005) and Rag1-/- mice (Mombaerts et 
al., 1992) were purchased from Jackson Laboratory. Ptf1aYFP/+ (Burlison, Long, Fujitani, Wright, 
& Magnuson, 2008) and MIP.GFP mice (Hara et al., 2003) were genotyped as previously 
described.  
 
Mutant alleles and genotyping 
The Rosa263TF.mCherry,  Rosa26Neurog3.CFP,  Rosa26Pdx1.YFP and Ptf1artTA alleles were derived 
by recombinase-mediated cassette exchange using mouse ES cells (mESCs) that had been 
previously engineered to contain loxed cassette acceptor alleles with methods that have been 
previously described (S. X. Chen et al., 2011). The exchange vector for Rosa263TF.mCherry was 
made by cloning both the mCherry DNA sequences and a 2A peptide-based expression cassette 
containing sequences for Neurog3, Pdx1, and MafA into separate sites of a pTRE-Tight-BI 
vector (Clontech). The bi-Tet operator assemblage was then inserted between the Lox71 and 
Lox2272 sites in pMCS.71/2272.Hygro. The exchange vector for Rosa26Neurog3.CFP was made by 
cloning both the CFP (Cerulean) Neurog3 and DNA sequences into pTRE-Tight-BI vector 
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(Clontech). The bi-Tet operator assemblage was then inserted between the Lox71 and Lox2272 
sites in pMCS.71/2272.Hygro. The exchange vector for Rosa26Pdx1,YFP was made by cloning both 
the YFP (Yellow fluorescent protein) and Pdx1 DNA sequences into pTRE-Tight-BI vector 
(Clontech). The bi-Tet operator assemblage was then inserted between the Lox71 and Lox2272 
sites in pMCS.71/2272.Hygro. The bi-Tet operator assemblage was then inserted between the 
Lox71 and Lox2272 sites in pMCS.71/2272.Hygro. For the Ptf1artTA allele, pPtf1a.Ex, a plasmid 
containing two inverted LoxP sites flanking the Ptf1a gene sequences and a FRT-flanked 
Hygromycin-resistance cassette, was modified using standard methods to insert the 5’ UTR 
sequences from X. laevis, rtTA sequences from pTET-ON Advanced vector (Clontech), and an 
intron-containing rabbit β-globin poly A site. After electroporation of the exchange vectors into 
Rosa26LCA (S. X. Chen et al., 2011) and Ptf1aLCA containing mESCs (Burlison et al., 2008) 
respectively, clones surviving dual selection with hygromycin (Invitrogen) and gancyclovir 
(Sigma) were screened by PCR (Table 2.1). Blastocyst microinjections, chimeric matings and 
excision of the FRT-flanked hygromycin selection cassette were performed as previously 
described (S. X. Chen et al., 2011).   
 
Microscopy  
mCherry fluorescence intensity measurements in unfixed tissues were performed using a 
Leica MZ16 FA stereoscope at an exposure time of 39.5 milliseconds. For paraffin sections, 
pancreatic tissue was fixed with 20% formaldehyde and processed by the Vanderbilt Tissue 
Pathology Shared Resource (TPSR). H&E, Masson’s Trichrome Blue, CD3, F4/80, and 
Cytokeratin staining was performed by TPSR according to manufacturer’s directions. For routine 
immunodetection using frozen sections, whole pancreata were fixed for 4 hours at 4°C in 4% 
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paraformaldehyde in PBS, washed three times in PBS, and incubated overnight at 4°C in 30% 
sucrose in PBS. Fixed tissues were then embedded in O.C.T. (Tissue Tek) and frozen on dry ice. 
8 µm sections were permeabilized for 30 minutes with 0.1% Triton X-100 in PBS and then 
preincubated with blocking solution (0.5% bovine serum albumin in PBS with 0.2% Tween-20 
(PBS-T)) for 1 hour before applying primary antibody (Table 2.2 ). Primary antibodies were 
diluted in blocking solution, incubated overnight at 4°C, then washed 3 times with PBS-T. The 
slides were incubated with secondary antibodies (Table 2.3) diluted in blocking solution for 2 
hours, washed three times in PBS-T and once in PBS, and then mounted with Prolong Gold with 
DAPI (Invitrogen).  
 Images were acquired using a Zeiss Axioplan-II upright microscope or a LSM 710 
META inverted confocal microscope and then pseudo-colored using either ImageJ (NIH) or 
Zeiss LSM browser software. All images are representative of phenotypes observed in at least 
three different animals.  
 
Adenovirus construction and injection 
The AdV-CMV-3TF virus was made using pAd/CMV/V5-DEST (Invitrogen). High titer 
virus (6.5 x1010 plaque-forming units (pfu)) was obtained by purification (Vector BioLabs). Mice 
were subjected to laparotomy under general anesthesia (Ketamine/Xylazine). The splenic lobe of 
the dorsal pancreas of 8 week old Rag1-/- mice was injected with 100 µl of purified AdV-CMV-
3TF (2x1010 pfu) and AdV-CMV-GFP (1x109 pfu) (Vector BioLabs) and animals were 
euthanized 7 days later. 
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Macrophage depletion 
To study the effect of macrophages on the outcome of 3TF-mediated acinar cell 
reprogramming, 6-8 week old mice were intravenously injected with either saline (control) or 
gadolinium chloride (GdCl3) (10 mg/kg, every 2 days for 1 week prior to dox treatment and then 
every 3rd day during dox treatment) and administered dox (2.0 or 0.2 mg/ml). Pancreata were 
harvested 7 days after dox. Only animals in which macrophages were reduced to less than 15% 
of the total DAPI-stained cells were used in the study.  
 
Physiological studies 
Adult mice were rendered diabetic with a single intraperitoneal injection of 
streptozotocin (180 mg per kg body weight dissolved in citrate buffer (pH 4.5)) after 4 hours fast. 
Mice with blood glucose levels >300 mg/dL were used for experiments. Glucose tolerance test 
was performed by fasting animals overnight  (16-hours) followed by an intraperitoneal injection 
of D-glucose (2 g per kg body weight). Blood glucose concentrations were measured using a BD 
Logic glucometer. 
 
FACS and RNA extraction 
Pancreata were removed, perfused with 2.0 mg/mL collagenase P (Roche) in HBSS, 
minced and incubated at 37°C for 5 minutes. Cells were further dispersed by manual pipetting, 
washed with FACS staining buffer (R&D Systems), filtered through a 100 µm mesh cell strainer, 
then centrifuged. Cell pellets were resuspended in AccuMax (Sigma) and DNase1 (Ambion) and 
incubated at 37°C for 4 minutes. Afterwards, cells were washed with FACS staining buffer, 
centrifuged, and resuspended in FACS buffer containing DNAse1 (1 U/ml, Ambion) and 1 mM 
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EDTA. DAPI was used to stain for cell viability at a dilution of 1:1,000. Viable mCherry+ cells 
were sorted into TRIzol LS (Invitrogen) and total RNA was isolated using TRIzol LS 
(Invitrogen), DNase-treated, and column-purified (Zymo Research) as previously described 
(Osipovich et al., 2014). 
 
Immunoblot analysis  
Pancreatic tissues were lysed in 20 mM Tris, pH 7.4, 20 mM NaCl, 1 mM EDTA, 20 mM 
beta-glycerophosphate, 5 mM EGTA, 1 mM PMSF, 1 µg/ml DTT, and 1x protease inhibitor 
(Sigma, P8340). Proteins were size fractionated in 4-20% SDS-PAGE gels (BioRad), transferred 
to polyvinylidene difluoride membranes (Millipore), blocked in 5% milk (BioRad) in PBS-T for 
3 hours, then incubated with goat anti-Pdx1 (1:100; BCBC) or mouse anti-β actin (1:1000, 
Sigma) overnight at 4°C. The membranes were then washed, incubated with anti-goat and anti-
mouse horseradish peroxidase-conjugated antibodies (Sigma) for 1 hour, washed again, then 
imaged using Western Lightning Plus ECL chemiluminescence kit (Perkin Elmer). 
 
Luciferase Reporter Assays 
 The NeuroD1- and Insulin II-luciferase fusion gene constructs were previously described 
(Anderson et al., 2009; Zhao et al., 2005) as well as the design of the cytomegalovirus (CMV) 
enhancer-driven p300 (Lee et al., 2012), Beta2 (Qiu, Sharma, & Stein, 1998), and rtTA 
(Clontech 631069) expression vectors. Coding sequences for Neurog3, MafA, and Pdx1 were 
cloned into TRE-Tight (Clontech) in order to compare the function of the wild-type to the 2A 
peptide-modified variants. HeLa and Panc1 cell lines were grown in Dulbecco’s modified 
Eagle’s medium using 10% heat-inactivated fetal bovine serum, 25 mM glucose, penicillin (100 
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units/ml), and streptomycin (100 units/ml). To test the functionality of 2A peptide-modified 
MafA and Pdx1, HeLa cells were co-transfected in 6-well plates with CMV-driven rtTA (0.375 
µg), p300 (0.375 µg), and Beta2 (0.375 µg) expression vectors and dox-inducible MafA (0.375 
µg), Pdx1 (0.375 µg), or 3TF (0.375 µg) expression vectors in the presence of either -238 wild-
type Insulin (0.375 µg), -238 Ins C1 mutant (0.375 µg), or -238 Ins A1/A3 mutant (0.375 µg) 
luciferase vectors. To test the functionality of 2A peptide modified Neurog3, Panc1 cells were 
co-transfected in 6-well plates with rtTA (0.5 µg) and either Neurog3 (0.5 µg) or 3TF (0.5 µg) in 
the presence of either the NDFull (0.5 µg) or NDΔ1 (0.5 µg) expression vectors. All 
transfections were performed using Polyfect Transfection reagent (Quiagen 301105) in the 
presence of dox (50 µM). A CMV-driven Renilla luciferase expression vector (7.5 ng) was used 
to correct for differences in transfection efficiency. Fusion gene expression was measured 40–48 
hours after transfection using a Dual Luciferase reporter assay system (Promega) and an 
automated luminometer (BioTek). Each transfection condition was tested in triplicate (n=3). 
Firefly luciferase readings were normalized to Renilla luciferase values.  
 
RNA-seq pre-processing and differential expression analyses 
Three independent RNA isolates from each genotype were used for sequencing. RNA-
sequencing methods were described previously (E. Choi et al., 2012). Single-end sequencing 
(110 bp) was performed on Illumina HiSeq2000 genome analyzer. Read alignment to the mouse 
genome (mm10) was performed using RNA-Seq Unified Mapper (RUM) (Grant et al., 2011). 
Genome alignment of sequencing data yielded 32-84 million uniquely mapped reads. Data was 
pre-processed with the PORT pipeline (https://github.com/itmat/Normalization). PORT extends 
the idea of resampling to resample for more than just read depth, but also for 
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exon/intron/intergenic balance and ribosomal depletion balance (Li & Tibshirani, 2013). 
Moreover, PORT enables for separate treatment of genes that are predominantly expressed in a 
subset of the samples. This is particularly important in my case due to the peculiar composition 
of the acinar cell mRNA population. 90-95% of the mRNA molecules in a pancreatic acinar cell 
code for fewer than 30 secretory enzymes (Harding et al., 1977) and the Amylase-2a and 
Trypsinogen gene families have nearly identical members that account for nearly half of the 
mRNA molecules. Differential expression of non-protease genes was analyzed with edgeR (FDR 
0.01)  (McCarthy, Chen, & Smyth, 2012) and PADE (FDR 0.1) (https://github.com/itmat/pade; 
an extension of PaGE,(Grant, Liu, & Stoeckert, 2005)) in my 1 and 7 day induced acinar cells 
compared to uninduced acinar cells. Genes that were found to be differential expressed by both 
approaches were considered differential expressed. Functional Annotation Clustering was 
performed using DAVID Bioinformatics Resources v.6.7 (Huang da, Sherman, & Lempicki, 
2009). 
cDNA was prepared from RNA using a high-capacity cDNA Archive Kit (Life 
Technologies) and amplified using real-time PCR with Power SYBR Green PCR master mix 
(Life Technologies) using gene specific primers (Table 2.1). Three experimental RNA replicates 
for each genotype were assayed. PCR was performed with an ABI 7900HT real-time PCR 
system (Life Technologies) and amplification data were analyzed using Sequence Detection 
System version 2.1 (Life Technologies) and Excel software (Microsoft). Hprt was used as 
endogenous housekeeping control for normalization and comparative Ct method was used to 
calculate relative fold expression by 2−ΔΔCt. 
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Quantification of necrosis 
Necrosis in pancreatic acini was quantified as previously described (Liu et al., 2014; 
Yuan et al., 2012). Quantification of necrosis was performed on pancreatic tissue (collected after 
2 day of 2.0 mg/ml dox) sections stained with H&E. Cells with swollen cytoplasm, loss of 
plasma membrane integrity, and leakage of organelles into interstitium were considered necrotic. 
Over 1000 acinar cells were counted from each mouse and three mice per condition were 
counted.  
 
Cell quantification and statistics 
Cells co-expressing specific genes were determined by manual counting. For each 
animal, over 500 cells were counted using ImageJ from five sections per animal that were 
separated by approximately 50 µM. All key experimental findings were observed in 3 or more 
animals. The total number of cells in the adult mouse pancreas was previously calculated (Dore, 
Grogan, Madge, & Webb, 1981) and used to determine the number of new beta cells produced. 
Statistical difference between two groups was assessed using Student’s t-tests. All data represent 
mean + SEM. 
 
Accession number 
The RNA-seq data and annotation have been submitted to ArrayExpress with accession 
ID: E-MTAB-3921. 
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Table 2.1 Primers used 
Primer Sequence (5’ to 3’) Product (bps) Application 
Rosa26.S1 
 
Hygro-3’ 
AGACTTATCTACCTCATAGGTG 
 
GTGAGAACAGAGTACCTACAT 
 
761 
Screening of RMCE-
derived mESCs 
Rosa26.R1  
 
Rosa26.S2 
GAGGATCATAATCAGCCATACC  
 
TCACAAGCAATAATAACCTGTAGT 
 
512 
Screening of mESCs 
and genotyping of 
ROSA3TF.mCherry allele 
F-p48 
 
R-5’p48 
CCTTCTGACTTCTCCAAGAAGGCA 
 
CCCTTTATGCCTGGCATTTCACTG 
Targeted: 670 
Wild-type: 636 
Genotyping of 
Ptf1artTA allele 
Ins1-Fwd 
 
Ins1-Rv 
CCAGCCCTTAGTGACCAGCTAT 
 
CCCAGGCTTTTGTCAAACAG 
143 
(exons 1-2) 
RT-qPCR of Ins1 
Ins2-Fwd 
 
Ins2-Rv 
CCACCCAGGCTTTTGTCAAA 
 
CCCAGCTCCAGTTGTTCCAC 
149 
(exons 2-3) 
RT-qPCR of Ins2 
Hprt-Fwd 
 
Hprt-Rv 
TACGAGGAGTCCTGTTGATGTTGC 
 
GGGACGCAGCAACTGACATTTCTA 
138 
(exon 9) 
RT-qPCR of Hprt 
(Endogenous control) 
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Table 2.2 Primary antibodies for immunohistochemistry 
Antigen Species Dilution Source Catalog # 
Amylase Goat 1:100 Santa Cruz Biotechnology SC-212821 
CD45 Rat 1:50 BD Biosciences 550539 
Chromogranin A Rabbit 1:1000 Abcam ab15160 
Cytokeratin Rabbit 1:500 Dako  Z0226 
F4/80 Rat 1:50 Invitrogen  MF48000 
GFP Chicken 1:1000 Invitrogen A10262 
Ghrelin Rabbit 1:1000 Phoenix Pharmaceuticals G-031-30 
Glucagon Rabbit 1:1000 Linco 4030-01F 
Insulin Guinea pig 1:1000 Invitrogen 18-0067 
MafA Rabbit 1:500 Bethyl laboratories IHC-00352 
Neurog3 Goat 1:1000 BCBC AB5684 
Pancreatic polypeptide Guinea pig 1:1000 Linco 4041-01 
Pdx1 Guinea pig 1:1000 Gift from Chris Wright  
RFP Rabbit 1:1000 Rockland 600-401-379 
RFP Chicken 1:1000 Rockland 600-901-379 
Somatostatin Sheep 1:1000 American Research Products 13-2366 
 
Table 2.3 Secondary antibodies for immunohistochemistry  
Target Species Host Species Fluorophore Dilution Source 
Chicken  
 
 
Donkey 
Cy3 1:1000 Jackson ImmunoResearch 
Goat Alexa Flour 488 1:1000 Invitrogen 
Rabbit Alexa Flour 488  1:1000 Invitrogen 
Rabbit Alexa Flour 555 1:1000 Invitrogen 
Rat Alexa Flour 488 1:1000 Invitrogen 
Sheep Alexa Flour 488 1:1000 Invitrogen 
Chicken   
Goat 
Alexa Flour 555 1:1000 Invitrogen 
Guinea pig Alexa Fluor 488 1:1000 Invitrogen 
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CHAPTER 3 
 
DESIGN AND VALIDATION OF A DIALLELIC, TRANSGENE-BASED MODEL FOR THE 
OVEREXPRESSION OF NUEROG3, PDX1, AND MAFA IN PANCREATIC ACINAR 
CELLS 
 
Introduction 
Cellular reprogramming is a potential therapy for replacing beta cells destroyed by 
autoimmune attack in T1D (Bramswig et al., 2013; W. Li, M. Nakanishi, et al., 2014; Thorel et 
al., 2010; Zhou et al., 2008). Towards this end, in 2008 it was reported that adenoviral-mediated 
expression of three pancreas-specific transcription factors MafA, Pdx1, and Neurog3 (3TF) in 
immunocompromised mice resulted in the conversion of pancreatic acinar cells into new insulin-
secreting beta-like cells (Zhou et al., 2008). In order to gain a better understanding of 
A→β conversion, the Magnuson lab derived a novel mouse model that enables simultaneous 
expression 3TF and a fluorescent reporter in a pancreatic acinar cell- and doxycycline-dependent 
manner. In this chapter, I discuss the derivation and validation of the transgenic mouse model.  
 
Tet-regulated alleles 
An effective system for regulating gene expression in mice is the diallelic, tet-regulated 
gene expression system (Freundlieb, Schirra-Muller, & Bujard, 1999; Lamartina et al., 2003), 
which has been used successfully for many in vitro and in vivo experiments, including adult 
pancreas studies (Hale et al., 2005; Holland, Hale, Kagami, Hammer, & MacDonald, 2002). The 
original Tet-Off strategy consists of a tetracycline-inhibited tet-TransActivator (tTA) driver and 
a tTA-dependent tetO-promoter responder gene. The Tet-On strategy consists of two parts: a 
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reverse-tetracycline transactivator (rtTA) driver gene and a tetracycline dependent responder 
gene. When coupled with the use of a cell-restricted promoter, both the Tet-Off and Tet-On 
strategies enable exquisite control of transgene expression. 
 
Ptfa1a 
Ptf1a (p48) is crucial for pancreas development and function and also serves as a specific 
marker for adult pancreatic acinar cells. Ptf1a is the defining central component of the trimeric 
PTF1 complex that plays important roles in both pancreas development and the maintenance of 
pancreatic acinar cell identity (Jonsson, Carlsson, Edlund, & Edlund, 1994; Kawaguchi et al., 
2002; Krapp et al., 1998; Offield et al., 1996; Rose, Swift, Peyton, Hammer, & MacDonald, 
2001; Roux, Strubin, Hagenbuchle, & Wellauer, 1989).  During early organogenesis, Ptf1a (in 
the trimeric PTF1RBPJ isoform comprising Ptf1a, E47 and RBPJ) commits cells to the pancreatic 
MPC state in the undifferentiated, nascent pancreatic rudiment (Kawaguchi et al., 2002; Masui et 
al., 2008). Midway through development, PTF1RBPJ increases the level RBPJL expression, 
resulting in change in the composition of the PTF complex to PTF1RBPJL (Hale et al., 2005; 
Masui, Long, Beres, Magnuson, & MacDonald, 2007; Masui et al., 2010).  PTF1RBPJL activates 
many acinar-specific target genes, including many for digestive enzymes (Holmstrom et al., 
2011; Masui et al., 2010), which are crucial for the terminal differentiation of acinar cells and for 
maintaining the acinar phenotype in adult pancreas.  PTF1RBPJL, which does not bind the Notch 
intracellular domain (Beres et al., 2006), auto-regulates itself through the Ptf1a promoter-
enhancer to reinforce and maintain its expression (Masui et al., 2008).   
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Results 
	
Design and validation of mouse alleles 
 To better understand the cellular dynamics of pancreatic A→β reprogramming, the 
Magnuson lab developed a diallelic transgene-based mouse model that co-expresses both 3TF 
and mCherry in a pancreatic acinar cell- and doxycycline-dependent manner (Figure 3.1A). The 
first allele was made by replacing the coding sequences for Ptf1a with those for rtTA. In the 
second allele, a bi-directional Tet-operator cassette that in one direction expresses a 2A peptide-
linked fusion gene of MafA, Pdx1, and Neurog3 and in the other direction the red fluorescent 
protein mCherry, was inserted into a functionally disabled Rosa26/SetD5 gene locus (S. X. Chen 
et al., 2011). When adult mice containing both the Ptf1artTA and Rosa263TF.mCherry alleles were 
given 2.0 mg/ml dox in their drinking water for 1 day, red fluorescence was observed in the 
pancreas but no other visceral organs (Figure 3.1B,C). Immunofluorescent staining for mCherry 
and for the acinar cell marker amylase, showed that 78% (+ 2.5%; n=3) of acinar cells expressed 
mCherry, and staining for mCherry and for each of the reprogramming factors showed that 
virtually all mCherry+ cells expressed the reprogramming factors (Figure 3.2A). Furthermore, 
after 1 day of dox, mCherry expression was restricted to the pancreatic acinar cells and was not 
observed in pancreatic ducts or endocrine cells, as expected due to the well-established acinar 
cell-restricted expression of Ptf1a (Figure 3.1C and Figure 3.2B).  
To further validate this experimental model, the function of the 2A peptide-cleaved 
transcription factors generated by the Rosa263TF.mCherry allele was analyzed. First, immunoblot 
analysis for PDX1, which is flanked by MAFA and NEUROG3 protein sequences in the 2A 
peptide containing cassette, showed it to be properly cleaved from the two surrounding proteins 
(Figure 3.2C). Second, analysis of protein function using reporter genes showed that each of the 
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2A peptide-modified proteins functioned in a normal manner, indistinguishable from that of their 
wild-type counterparts (Figure 3.3). Third, when Rosa26rtTA was used to drive expression of 
3TF, insulin+ cells are induced within 3 days in intestinal crypts (Figure 3.4A), a previously 
reported finding (Y. J. Chen et al., 2014). Fourth, a recombinant adenovirus containing the 3TF 
fusion gene, when injected together with a GFP-expressing virus into the pancreas of Rag1-/- 
mice, resulted in scattered insulin+/GFP+ co-expressing cells within the exocrine compartment of 
the pancreas, similar to those observed by Zhou et al. (Zhou et al., 2008) (Figure 3.4B,C). 
Together, these findings confirmed that the 2A peptide-modified MAFA, PDX1 and NEUROG3, 
made in response to dox-induction, functioned normally. 
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Figure 3.1 Mouse model for the acinar cell- and doxycycline-dependent overexpression of 
3TF. (A) Ptf1artTA and Rosa263TF.mCherry alleles were generated by recombinase-mediated cassette 
exchange. When interbred, the two alleles resulted in dox-inducible expression of MafA, Pdx1, 
Neurog3, and mCherry in a pancreatic acinar cell-specific manner. (B) mCherry expression was 
visible after administering 2.0 mg/ml of dox for 1 day (n=5). mCherry fluorescence was restricted 
to the pancreas (outlined) of dox treated mice and was not observed in other tissues. (C) Dox-
inducible, acinar cell-specific expression of mCherry was confirmed with immunofluorescence 
analysis. Pancreas sections stained with insulin and mCherry showed that the two proteins were 
not co-localized.	
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Figure 3.2 Reprogramming factors are expressed specifically in pancreatic acinar cells.  (A) 
Pancreas sections stained with antibodies against mCherry and either MafA, Pdx1, or Neurog3 
showed co-expression of mCherry and 3TF after 1 day of dox. (B) After 1 day of dox, mCherry 
was not expressed in glucagon-, pancreatic polypeptide-, or somatostatin-expressing endocrine 
cells, or in ductal cells, marked by PanCK staining. (C) Schematic of the transgene showing that 
the protein sequences for MAFA and NEUROG3 flank PDX1. To determine whether proper 2A 
mediated cleavage of 3TF was achieved, western blot against PDX1 was performed on pancreatic 
lysate from wild-type (WT) and 7 day induced, Ptf1artTA/+; Rosa263TF.mCherry/+ (3TF) mice. Arrows 
indicate both the 50 kDa PDX1 protein with the addition of the 2A peptide sequences and the 
endogenous PDX1 at 48 kDa 
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Figure 3.3 2A peptide-modified proteins function in a normal manner. (A) Promoter 
constructs used for Dual Luciferase Assay to test the functionality of the 2A peptide modified 
MAFA and PDX1 proteins. Constructs used were a wild-type (WT), MafA-binding mutant 
(mutant C1), or Pdx1-binding mutant (double mutant A1/A3) of the insulin promoter fused to 
luciferase. (B) Promoter constructs used for Dual Luciferase Assay to test the functionality of the 
2A peptide modified NEUROG3 protein. Constructs used were a WT NeuroD1 promoter fused to 
luciferase (NDFul) or a NeuroD1 promoter containing a deletion of the Neurog3 binding site 
fused to luciferase (NDΔ1). (C) Dual Luciferase Assay was performed in transfected HeLa cells 
using either the WT or mutated insulin promoter constructs. Control was no transcription factors.  
Data are represented as mean + SEM. **p < 0.001, student’s t-test, n=3. (D) Dual Luciferase 
Assay was performed in transfected Panc1 cells using either the WT or mutated NeuroD1 
promoter fused to luciferase. Control was no transcription factors. Data are represented as mean + 
SEM. **p < 0.001, student’s t-test, n=3. 
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Figure 3.4 Validation of mouse model (B) The splenic lobe of the dorsal pancreas of 8 week old 
Rag1-/- mice was injected with 100 µl of a purified 3TF-expressing adenovirus (AdV-CMV-3TF; 
2x1010 pfu) and a GFP-expressing adenovirus (AdV-CMV-GFP, 1x109 pfu). Animals were 
euthanized 7 days later. (C) Pancreatic immunofluorescence staining of insulin and GFP. Arrows 
indicate infected acinar cells that have been reprogrammed into insulin-expressing cells. 
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Discussion 
In order to investigate the cellular dynamics of 3TF-mediated A→β reprogramming, the 
Magnuson lab developed a biallelic transgenic mouse. This mouse model utilizes two different 
alleles, Ptf1artTA and Rosa263TF.mCherry, that allow for the dox-inducible expression of 3TF and 
mCherry specifically in pancreatic acinar cells. 2A peptide technology was used to 
simultaneously express 3TF and mCherry from a single transcript. To validate the biallelic 
mouse model and ensure that the 2A peptide-modified MAFA, PDX1, and NEUROG3, made in 
response to dox-induction, functioned normally, multiple validation studies were performed.  
First, I showed that 3TF/mCherry is expressed specifically in the pancreatic acinar cells 
in a dox-dependent manner. When biallelic mice are given 2.0 mg/ml dox in their drinking water 
for one day, red fluorescence is observed in the pancreas but no other visceral organs. 
Immunohistochemical staining for mCherry and for each of the reprogramming factors has 
shown that all four proteins are simultaneously expressed in at least 70% of acinar cells. 
Furthermore, immunohistochemical staining shows that mCherry expression is restricted to 
acinar cells and is not observed in pancreatic ducts or endocrine cells, as expected, due to the 
well-established acinar cell-restricted expression of Ptf1a, the driver gene for rtTA. 
Second, multiple validation studies to ensure that the three reprogramming factors 
functioned properly were performed. 1.  Immunoblotting has shown proper peptide-2A-mediated 
cleavage of the nascent protein transcript. 2. Reporter studies in cell lines have shown that the 2A 
peptide-modified factors each function in a manner indisguishable from the wild-type proteins. 3. 
When Rosa26rtTA was used to drive expression of 3TF, insulin+ cells were observed within 3 days 
in intestinal crypts, similar to a report by Chen et al. (Y. J. Chen et al., 2014). 5. Finally, when 
the 3TF cassette in Rosa263TF.mCherry allele was inserted into a recombinant adenovirus and 
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injected into the pancreas of Rag1-/- mice, I observed scattered insulin+ cells, precisely mimicking 
the results from Zhou et al. (Zhou et al., 2008).   
This mouse model allows me to express 3TF in the majority of pancreatic acinar cells in a 
regulated manner. With viral delivery of the factors, only a small portion of the acinar cells were 
infected, and only a few of the infected cells produced insulin. Use of the Tet-O system allows 
for the controlled expression of transgenes in the majority of pancreatic acinar cells. This make it 
possible to acquire enough tissue in sufficient purity for biochemical, cell-biological, and 
molecular analyses of synchronized cellular changes. Indeed, this mouse model enables 3TF 
expression to be modulated in a manner that is unachievable using a virus-based expression 
system, thereby allowing the effects of both 3TF concentration and duration on generating new 
beta-like cells to be examined.  
  
		
	
43	
CHAPTER 4 
 
TRANSGENE-BASED EXPRESSION OF NEUROG3, PDX1, AND MAFA CAUSES 
PANCREATIC INFLAMMATION AND ACINAR-TO-DUCTAL METAPLASIA 
 
Introduction 
The diallelic, transgenic mouse model that the Magnuson lab developed and validated, 
which expresses 3TF in both a pancreatic acinar- and dox-dependent manner, allows the 
dynamics of A→β reprogramming to be investigated. Such a model allows for both 3TF 
expression and duration to be modulated in a manner that is unachievable using a virus-based 
expression system. However, using this transgene-based mouse model, I was unable to achieve 
A→β reprogramming and found that robust 3TF expression causes acinar cell necrosis resulting 
in marked inflammation and ADM.  In this chapter, I discuss the effects of transgene-mediated 
3TF overexpression in pancreatic acinar cells on pancreatic histology and architecture.  
 
Acinar cell plasticity 
Acinar cells exhibit plasticity converting into endocrine cells (Baeyens et al., 2014; W. 
Li, C. Cavelti-Weder, et al., 2014; W. Li, M. Nakanishi, et al., 2014; Pan et al., 2013; Zhou et al., 
2008), duct cells (Kopp et al., 2011), and adipocytes (Bonal et al., 2009). The ability of acinar 
cells to undergo cellular conversions has significant implications for both health and disease. 
First, acinar cell reprogramming into beta cells represents a potential therapy for T1D. Second, 
the conversion of acinar cells into duct-like cells, also referred to as ADM, is a major contributor 
to the generation ductal of pancreatic intraepithelial neoplasia (PanINs) (Habbe et al., 2008), the 
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predecessors to pancreatic ductal adenocarcinomas (PDAC) (Habbe et al., 2008), one of the most 
deadly forms of cancer accounting for the fourth leading cause of cancer-related deaths in the 
United States (Siegel, Naishadham, & Jemal, 2013).  
In response to injury, the pancreas activates a regeneration process to maintain tissue 
homeostasis. In acinar cells, inflammation activates cytokines, inflammatory proteins, signaling 
pathways involved in stress, such as the unfolded protein response (UPR), and developmental 
and regeneration proteins (Pin, Ryan, & Mehmood, 2015).  Recent studies have shown that after 
injury, acinar cells undergo ADM where they dedifferentiate into a ductal epithelium that 
expresses early developmental factors. These duct-like cells are suggested to be “facultative 
progenitor cells” that, once inflammation is resolved, can re-differentiate into mature acinar cells 
(Husain & Thrower, 2009). However, when combined with Kras mutations, these cells have an 
increased chance of forming PanIN lesions (De La et al., 2008; Habbe et al., 2008).  A deep 
understanding of the molecular mechanism governing acinar cell plasticity is vital and may be 
exploited to drive acinar cells towards and endocrine cell fate and away from a potentially pre-
cancerous, duct-like cell.  
 
Results 
	
Lack of A→β  reprogramming in transgenic mice after 3TF induction 
 I was first interested to see if transgene-mediated 3TF expression resulted in the 
reprogramming of acinar cells into beta cells. Since viral mediated expression of 3TF in the 
pancreas has previously been reported to cause A→β conversion in 10 days or less (Zhou et al., 
2008), I treated my diallelic mice with dox for 1, 7, and 28 days and performed immunostaining 
for acinar and endocrine cell markers, including insulin. At 1 day, the 3TF-induced cells 
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resembled acinar cells with all mCherry+ cells seen to express amylase, an acinar cell-specific 
marker. However, at 7 and 28 days, the expression of amylase in mCherry+ cells was greatly 
diminished or absent (Figure 4.1). In addition, the mCherry+ cells were smaller in size and 
located in tubular-like cell clusters (Figure 4.1A). Chromogranin A, an endocrine cell marker 
that was absent in the 1 day sample, was expressed in nearly 100% of mCherry+ cells at 7 and 28 
days (Figure 4.2). Interestingly, despite the widespread expression of this endocrine marker in 
mCherry+ cells, I failed to observe any insulin, glucagon, somatostatin, or pancreatic polypeptide 
expression by immunofluorescence staining. However, after 7 days of dox treatment, I did 
observe that approximately 40% of mCherry+ cells expressed ghrelin, a hormone that is normally 
expressed in 1% or fewer adult pancreatic endocrine cells (Arnes, Hill, Gross, Magnuson, & 
Sussel, 2012). The portion of cells expressing ghrelin rose to nearly 60% in the 28 day sample 
(Figure 4.2).  
 
RNA profiling of the 7 day 3TF-treated cells 
To better understand why new beta-like cells were not observed and to corroborate the 
immunostaining results, I performed RNA-Seq on FACS-purified mCherry+ cells after 1 and 7 
days of dox administration and compared their transcriptional profiles to FACS-purified 
uninduced acinar cells (ArrayExpress:E-MTAB-3921). These datasets revealed that MafA, 
Pdx1, and Neurog3 mRNAs were all highly up-regulated after 1 day of dox treatment compared 
to uninduced acinar cells. Indeed, MafA increased from 0.67 + 0.67 to 4069 + 169, Pdx1 from 20 
+ 4 to 7037 + 471, and Neurog3 from 0 to 10931 + 629 normalized counts, strongly suggesting 
that the lack of insulin gene expression was not due to insufficient 3TF expression. Furthermore, 
inspection of the 7 day, 3TF-induced RNA-seq dataset showed that while some genes that 
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characterize either immature or mature beta cells, such as ChgA, Ghrl, Neurod1, and Insm1, were 
highly up-regulated compared to uninduced acinar cells, other genes that are normally present in 
beta cells such as Ins1, Ins2, Nkx6.1, Isl1, and Pax6 were not identified as significantly up-
regulated in the 3TF-induced acinar cells (Figure 4.3A and ArrayExpress:E-MTAB-3921). In 
addition, many of the endocrine-specific genes that were up-regulated have been previously 
shown to be direct DNA binding targets for either Neurog3, Pdx1, or MafA. For instance, 
Neurod1, Nkx2.2, and Insm1 are targets of Neurog3 (H. P. Huang et al., 2000; Smith et al., 2003; 
Watada et al., 2003), and Pdx1 binds to the promoters of both Gck and Slc2a2 (Khoo et al., 2012; 
Watada et al., 1996). Importantly, I also noticed that many of the upregulated genes from the 
RNA-seq data set of 7 day, dox-induced acinar cells were associated with inflammation (Figure 
4.3B). Taken together, these findings suggest that while 3TF expression increased expression of 
several endocrine-specific genes, it did not cause acinar cells to thoroughly adopt a beta cell-like 
gene expression profile. 
 
Transgene-based expression of 3TF results in acinar-to-ductal metaplasia 
 To confirm that inflammation-associated genes were expressed in response to 3TF-
induction, I began by staining pancreata for inflammatory cells using CD45, a pan-leukocyte 
marker, and observed that nearly a third of the cells present in the pancreas were leukocytes 
(Figure 4.4A, B). Further staining for F4/80, a macrophage marker, and CD3, a T-cell marker, 
revealed that both types of inflammatory cells were present with the majority being macrophages 
(Figure 4.5A, B). Finally, Masson’s trichrome staining revealed extensive fibrosis, further 
indicating a potent inflammatory response (Figure 4.5C).  
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Since inflammation in the pancreas has been linked to metaplastic changes, I examined 
the histological appearance of 7 day-induced pancreatic tissue. After 7 days of 3TF expression, 
pancreata of the diallelic mice were smaller than control mice (Figure 4.6A), were characterized 
by the presence of many tubular complexes (Figure 4.6B), and had marked acinar cell necrosis 
(Figure 4.6C), all of which are hallmarks of ADM (Jura, Archer, & Bar-Sagi, 2005; Parsa et al., 
1985). Immunostaining for cytokeratin, a marker for pancreatic duct cells, further revealed that 
the 3TF-expressing mCherry+ cells had adopted duct-like characteristics (Figure 4.7A, B). Since 
marked inflammation and metaplasia were not observed in my viral control experiments (Figure 
4.7C, D ) or previously reported by others when an adenovirus was used to introduce 3TF to the 
pancreas of normoglycemic mice (Cavelti-Weder et al., 2016; Zhou et al., 2008), I hypothesized 
that the overly robust 3TF expression that occurred using 2.0 mg/ml of dox was responsible for 
both the immune response and histologic changes consistent with ADM. 
 To determine why 3TF expression in my diallelic transgenic model was causing 
pancreatic inflammation, I considered the fact that pancreatic acinar cells are especially 
vulnerable to ER dysfunction owing to their high level of protein synthetic and secretory activity 
(Ji et al., 2003; Logsdon & Ji, 2013). In support of this notion, I noticed that 44 of 83 genes 
involved in the activation of the unfolded protein response were upregulated after 7 days of 3TF 
expression (Figure 4.8A). In addition, the expression of genes encoding voltage-gated and other 
Ca2+ channels (Figure 4.8B) were also markedly increased. In acinar cells, a rise in [Ca2+]i  has 
been associated with ADM and is known to cause activation of inflammatory genes and the ER 
stress response (Sah et al., 2014). These findings are consistent with activation of the ER stress 
response in 3TF-expressing acinar cells, most likely through a disruption in calcium homeostasis. 
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Figure 4.1 Amylase expression decreases during reprogramming. (A) Animals were induced 
for 1, 7, or 28 days with dox (2.0 mg/ml). Immunofluorescence analysis revealed that amylase 
expression in mCherry+ cells was present after 1 day of dox but decreased by 7 days and 
continued to decreased throughout the time course. (B) Percentage of cells expressing amylase 
among mCherry+ cells. Three mice per time point. Over 500 mCherry+ cells counted for each 
mouse. Data are represented as mean + SEM.  
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Figure 4.2 Expression of endocrine markers increase during reprogramming. (A) Animals 
were induced for 1, 7, or 28 days with dox (2.0 mg/ml). Immunofluorescence analysis revealed 
that the expression of the endocrine markers chromogranin A and ghrelin began at 7 days and 
increased during the reprogramming time-course. (B) Percentage of cells expressing 
chromogranin A and ghrelin among mCherry+ cells. Three mice per time point. Over 500 
mCherry+ cells counted for each mouse. Data are represented as mean + SEM.  
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Figure 4.3 Expression analysis of reprogrammed cells (A) Fold changes (log2 scale; 
pseudocounts added) in the expression of beta cell specific genes calculated from my RNA-seq 
data set of 7 day 3TF-induced acinar cells compared to uninduced acinar cells. These mRNAs 
were identified as significantly differentially expressed by both edgeR and PADE. (B) The top 
eleven functional annotation clusters compiled from the top 200 up-regulated genes in my RNA-
seq data set of 7 day 3TF-induced acinar cells compared to uninduced acinar cells using DAVID 
analysis. 
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Figure 4.4 Transgene-mediated 3TF expression in pancreatic acinar cells causes an 
infiltration of immune cells (A) Pancreatic immunofluorescence staining of CD45 from WT 
mice after 7 days of dox and 3TF mice after 1 and 7 days of dox. (B) Percentage of CD45+ cells 
among DAPI+ cells. Three mice per time point and over 1,000 DAPI+ cells counted for each 
mouse. Data are represented as mean + SEM. 
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Figure 4.5 Transgene-mediated 3TF expression in pancreatic acinar cells causes a potent 
inflammatory response. (A) Representative F4/80, (B) CD3, and (C) Masson’s trichrome stain 
of WT and Ptf1artTA/+; Rosa263TF.mCherry/+ (3TF) mice at 7 days dox treatment. 
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Figure 4.6 Transgene-mediated 3TF expression in pancreatic acinar cells causes  Acinar-to-
ductal metaplasia. (A) Representative pancreata and (B) hematoxylin and eosin (H&E) staining 
of WT and 3TF mice after 7 days of dox. Pancreas of 3TF mice is characterized by the presence 
of abundant tubular complexes (inset). (C) Acinar cell necrosis (arrow) was observed in the 
pancreata of 3TF mice treated with dox for 2 days. (E) Necrosis was measured on tissue sections 
stained with H&E from WT mice and 3TF mice treated with dox for 2 days. Necrosis is 
represented as the percentage of necrotic acinar cells among acinar cells. Three mice per group 
and over 1,000 acinar cells were counted for each mouse. Data are represented as mean + SEM. 
**p < 0.001, student’s t-test. 
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Figure 4.7 Transgene-mediated 3TF expression in pancreatic acinar cells causes the 
expression of ductal markers. (A) Pancreatic immunofluorescence staining of PanCK, a ductal 
marker, from WT mice after 7 days dox and 3TF mice after 1 and 7 days of dox. (B) Percentage 
of PanCK+ cells among mCherry+ cells. Three mice per time point and over 500 mCherry+ cells 
counted for each mouse. (C) The pancreas of 8 week old Rag1-/- mice was injected with 100 µl of 
a purified AdV-CMV-3TF (2x1010 pfu) and an AdV-CMV-GFP (1x109 pfu). Animals were 
euthanized 7 days later. Representative pancreatic immunofluorescence staining of PanCK (D) 
and CD45, 7 days post AdV-CMV-3TF, infection indicates that adenoviral delivery of my 3TF 
construct did not result in a potent inflammatory response or ADM. 
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Figure 4.8 Transgene-mediated 3TF-overexpression causes ER stress (A) Fold changes 
(pseudocounts added) in the expression of key genes recognizing and responding to misfolded 
protein accumulation in the ER calculated from my RNA-seq data set of 7 day 3TF-induced 
acinar cells compared to uninduced acinar cells. These mRNAs were found to be differentially 
expressed by both edgeR and PADE. (B) Fold changes (pseudocounts added) in the expression of 
Ca2+ Channels calculated from my RNA-seq data set of 7 day 3TF-induced acinar cells compared 
to uninduced acinar cells. These mRNAs were found to be differentially expressed by both edgeR 
and PADE. 
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Discussion 
By using a novel diallelic transgenic mouse model that expresses 3TF in both a 
pancreatic acinar- and dox-dependent manner, I found that 3TF expression in acinar cells does 
not result in new beta-like cells, but instead causes their conversion into duct-like cells due to 
ADM. Indeed, after 7 days of 3TF expression, many genes that serve to define a mature beta cell, 
including insulin, were not significantly expressed. 
Furthermore, 3TF expression caused acinar cell damage characterized by severe necrosis 
and a corresponding infiltration of macrophages. While pancreatic acinar cells are an attractive 
reprogramming target, due to their high degree of plasticity (Kopp et al., 2012; W. Li, M. 
Nakanishi, et al., 2014; Wallace, Marek, Currie, & Wright, 2009) and similar developmental 
pathway to beta cells, their function of producing and secreting digestive enzymes may pose 
challenges. Indeed, premature enzyme activation is a major contributor to pancreatitis, and under 
inflammatory conditions, acinar cells can undergo ADM. While in some instances inflammation 
promotes cellular reprogramming, such as the reprogramming of fibroblast to iPSCs (Lee et al., 
2012) or hepatocytes to beta-like-cells (A. Y. Wang, Ehrhardt, Xu, & Kay, 2007), in the 
pancreas, inflammation may prevent A→β reprogramming. It is possible that the conversion of 
acinar cells into a duct-like, progenitor cell takes precedence, especially since ADM may serve to 
protect the organ in the face of damage by preventing the continued production and activation of 
digestive enzymes that would likely result in continuing pancreatic damage.  
It is unclear as to why robust 3TF expression causes pancreatic inflammation and ADM. 
It is possible that a high concentration of 3TF causes a pathological increase in the [Ca2+]i in 
acinar cells, which triggers the premature activation of pancreatic zymogens such as trypsinogen, 
and activation of the ER stress response mechanism (Muili et al., 2013; Raraty, Petersen, Sutton, 
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& Neoptolemos, 1999; Sah et al., 2014). Indeed, inspection of my RNA-seq data revealed a 
marked increase in both the expression of genes encoding voltage-gated and other Ca2+ channels 
and of genes involved in the activation of the unfolded protein response after 7 days of robust 
3TF-transgene expression. Ca2+ plays a central role in controlling the secretion of digestive 
enzymes in pancreatic acinar cells and a rise in [Ca2+]i is a key event in the pathogenesis of 
pancreatitis with elevated [Ca2+]i levels causing  premature trypsin activation, necrosis, 
activation of inflammatory genes, and activation of the ER stress response (J. Li et al., 2014; Sah 
et al., 2014). 
Widespread metaplastic changes resulting from tissue inflammation have not been 
reported when adenoviruses are used to introduce the reprogramming factors into the pancreas of 
Rag1-/- normoglycemic mice (Cavelti-Weder et al., 2016). I speculate that under normoglycemic 
conditions similar metaplastic conversions that were observed with transgene-mediated 3TF-
expression are not observed due to the lower infection efficiency of the adenovirus. This results 
in fewer 3TF-expressing cells, thereby lowering the overall inflammatory potential. In addition, 
adenoviral delivery may result in lower levels of 3TF-expression compared to transgene-
mediated expression, which may also prevent acinar cell damage and the ensuing inflammation. 
In any case, it is clear that the dynamics of A→β reprogramming are more complex than 
previously thought, and that a better understanding of the many variables that are involved will 
be essential prior to testing the feasibility of A→β reprogramming in humans.  
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CHAPTER 5 
 
RAG1 AND ADENOVIRAL INFECTION DOES NOT INFLUENCE THE OUTCOME OF 
TRANSCRIPTION FACTOR-MEDIATED ACINAR CELL REPROGRAMMING 
 
Introduction 
Viral-mediated delivery of 3TF to the pancreas of Rag1-/- mice has been shown by Zhou 
et. al to reprogram pancreatic acinar cells into insulin-secreting beta-like cells (Zhou et al., 
2008). However, using a diallelic transgenic mouse model, I have found that transgene-mediated 
expression of 3TF does not result in the production of new beta-like cells. Instead, 3TF 
expression causes a marked immune response and ADM. Two obvious differences between my 
experimental design compared to that of Zhou et al. was the use of a transgene to express 3TF, 
opposed to a viral vector, and the presence of Rag1 (Zhou et al., 2008).  On account of this, I 
tested whether one or both of these experimental variables might account for the divergent 
reprogramming outcome observed and have found that neither Rag1 nor viral infection 
influenced the reprogramming outcome. In this chapter, I will discuss my findings on the role of 
Rag1 and adenoviral infection on the outcome of 3TF-mediated A→β reprogramming. 
 
Rag1 
Rag1 is an enzyme essential for the maturation of B- and T-cells, and its deletion results 
in the complete absence of both T- and B-cells (Mombaerts et al., 1992). Since T-cells are 
important in controlling the early innate immune response and regulating macrophage 
polarization, deletion of Rag1 also alters the innate immune response resulting in an increase of 
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M1 macrophage functionality as well as a reduced M2 macrophage profile (Chan, Pek, Huth, & 
Ashkar, 2011). Indeed, macrophages form a heterogeneous population of cells within the 
mononuclear phagocyte system and are potent immune regulators playing an important role in 
tissue remodeling and homeostasis. Furthermore, in the face of pancreatic damage, M1 
macrophages can drive ADM (Liou et al., 2013). Initially, I believed that use of immunodeficient 
mice would be unnecessary when using a transgene, not a virus, to express 3TF. However, after 
being unable to reprogram acinar cells into new beta−like cells in Rag+/+ mice, and observing a 
cellular infiltrate of macrophages after inducing 3TF transgene expression, I hypothesize that the 
altered immune response in Rag1-/- mice facilitates A→β reprogramming. 
 
Adenoviral infection 
Reprogramming methods routinely utilize adenoviral vectors, which allow for transient 
expression of exogenous genes without integration into the host genome (Stadtfeld, Nagaya, 
Utikal, Weir, & Hochedlinger, 2008). In some settings, the use of a viral vector is required for 
successful reprogramming (Lee et al., 2012; A. Y. Wang et al., 2007; Zaldumbide et al., 2012).  
Indeed, viral infection and adenoviral regulatory proteins, such as E4-ORF3, have been shown to 
activate host immune response pathways resulting in epigenetic changes that improve the 
binding of the reprogramming factors to their targets (Lee et al., 2012; Zaldumbide et al., 2012). 
These findings support the notion that an open chromatin state improves reprogramming 
efficiency. Acinar cells are littered with repressive histone modifications and compared to alpha 
and beta cells, exocrine cells exhibit many more genes marked with the repressing H3K27me3 
histone modification (Bramswig et al., 2013). Indeed, the addition of chromatin modifying 
agents that alter the chromatin structure to a more “open” state has also been shown to improve 
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reprogramming efficiency of iPSCs (Huangfu et al., 2008; Mali et al., 2010; Shi et al., 2008). 
Thus, I hypothesis that adenoviral infection alters the epigenetic landscape of acinar cells in a 
manner that enables successful 3TF-mediated A→β reprogramming.   
 
Results 
	
The presence or absence of Rag1 or adenovirus infection does not alter the reprogramming 
outcome 
 Given that new beta cells were observed only when 3TF was expressed by an adenoviral 
vector, but not from a transgene, I performed several experiments to exclude a role for two 
experimental variables that might have accounted for this divergent reprogramming outcome. 
The first experimental variable was the presence or absence of Rag1 (Zhou et al., 2008), a gene 
required for V(D)J recombination in B and T cells (Mombaerts et al., 1992). Rag1 null mice 
were used in the adenoviral expression studies to prevent clearance of the transcription factor-
expressing viruses whereas the transgene-based expression studies utilized Rag1+/+ animals since 
viral clearance was not an issue. Since it is possible that the lack of mature B and T lymphocytes 
in Rag1-/- mice might modulate the inflammatory response and allow reprogramming to occur, I 
crossed the Rag1 null allele into my diallelic mice to derive Ptf1artTA/+; Rosa263TF.mCherry/+; Rag1-
/- mice and then treated these mice with dox for 7 days. Pancreas immunostaining for CD3 
showed that T cells were indeed absent (Figure 5.1A). However, despite the absence of Rag1, 
many F4/80+ cells were observed in the pancreas after 7 days of dox treatment (Figure 5.1B), 
and similar to the Rag1+/+ mice, many cytokeratin+ tubular complexes were formed (Figure 
5.1C and 5.2A) that expressed ghrelin (Figure 5.2C). Masson’s trichrome staining again 
revealed extensive fibrosis (Figure 5.2B) and, more importantly, there were no cells that co-
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expressed mCherry and insulin (Figure 5.2D). Thus, these findings showed that the presence or 
absence of Rag1 has no substantive role in determining the reprogramming outcome when I used 
2.0 mg/ml dox to induce 3TF expression. 
The second experimental variable was the presence or absence of adenoviral infection. 
Since it has been reported that viral infection and the presence of adenoviral regulatory proteins 
could improve reprogramming efficiency (Lee et al., 2012; A. Y. Wang et al., 2007; Zaldumbide 
et al., 2012), I simultaneously induced 3TF expression for 7 days using 2.0 mg/ml dox while also 
injecting a GFP-expressing adenovirus directly into the pancreas (Figure 5.3A, B). Once again, 
and despite examining over 600 mCherry and GFP co-expressing cells, no cells were seen that 
also expressed insulin (Figure 5.3D). Instead, many of the mCherry and GFP co-expressing cells 
continued to express ghrelin (Figure 5.3C). These findings enabled us to exclude the host 
immune response to viral infection as having a major role in the divergent reprogramming 
outcome when using 2.0 mg/ml dox to induce 3TF expression. 
 
  
		
	
62	
  
 
Figure 5.1 Rag1 deletion does not prevent macrophage infiltration or pancreatic histological 
changes. (A) Representative CD3 stain of WT and Ptf1artTA/+; Rosa263TF.mCherry/+; Rag1-/- (3TF. 
Rag1-/-) mice at 7 days dox (2.0 mg/ml) treatment. No CD3+ cells are observed in WT or 
3TF.Rag1-/- mice. (B) Representative F4/80 stain of WT and 3TF. Rag1-/- mice at 7 days dox 
treatment. (C) H&E staining of WT and 3TF. Rag1-/- mice after 7 days dox administration. 
Pancreas of 3TF. Rag1-/- mice is characterized by the presence of abundant tubular complexes 
(inset).  
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Figure 5.2 Rag1 deletion does not alter the outcome of reprogramming. (A) Representative 
PanCK stain and (B) Masson’s trichrome stain of WT and 3TF. Rag1-/- mice at 7 days dox (2.0 
mg/ml) treatment. (C) Pancreatic immunofluorescence ghrelin staining of 3TF. Rag1-/- mice at 7 
days dox treatment. Multiple mCherry+ cells co-express ghrelin. (D) Pancreatic 
immunofluorescence insulin staining of 3TF. Rag1-/- mice at 7 days dox treatment. No mCherry+ 
cells that co-express insulin were observed despite examining over 1,000 mCherry+ cells. 
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Figure 5.3 Adenoviral infection is not required for 3TF-mediated A!β reprogramming.  
(A) Schematic to test if the adenoviral capsid or viral infection is required for 3TF-mediated 
A→β reprogramming. 6- 8 week old 3TF mice were injected with 100 µl of AdV-CMV-GFP 
(1x109 pfu) then administered dox (2.0 mg/ml) for 7 days. (B) Representative pancreas of 3TF 
mice infected with an AdV-CMV-GFP and administered 2.0 mg/ml of dox at 7 days. Successful 
pancreatic injection of the AdV-CMV-GFP is demonstrated by GFP fluorescence. (C) Pancreatic 
immunofluorescence ghrelin staining of 3TF mice at 7 days of dox treatment and AdV-CMV-
GFP infection. Multiple mCherry+ cells co-express ghrelin and the GFP-expressing adenovirus. 
(D) Pancreatic immunofluorescence insulin staining of 3TF mice at 7 days of dox treatment and 
AdV-CMV-GFP infection. No mCherry+ cells that co-express insulin and GFP were observed 
despite examining over 600 mCherry+/GFP+ cells. 
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Discussion 
Two differences between my experimental design compared to that of Zhou et al. was the 
use of a transgene to express 3TF, opposed to a viral vector, and the presence of Rag1 (Zhou et 
al., 2008). Thus, it is possible that one or both of these experimental variables might account for 
the divergent reprogramming outcome observed. In some settings, viruses are required for 
successful reprogramming by activating host immune response pathways that ultimately result in 
epigenetic changes that improve the binding of the reprogramming factors to their targets (Lee et 
al., 2012). Adenoviral regulatory proteins, such as E4-ORF3, were also proposed to alter 
chromatin accessibility for reprogramming factors (Zaldumbide 2012). However, when I 
simultaneously expressed 3TF by dox administration and infected the pancreas of my biallelic 
mice with a GFP-expressing adenovirus, none of the 3TF-expressing acinar cells that had been 
infected with the adenovirus co-expressed insulin. While this experiment does not fully exclude a 
role of viral infection, it suggested that the lack of A→β reprogramming in the transgenic mouse 
model was due to some other factor when using 2.0 mg/ml dox to induce 3TF expression. 
Similarly, since T cells modulate innate immune responses and regulate macrophage polarization 
(Chan et al., 2011), I considered the possibility that the use of Rag1-/- mice by Zhou et al. might 
account for the differences in experimental outcome (Zhou et al., 2008). However, when I 
examined the effect of Rag1 null background on the reprogramming outcome, despite the 
absence of T cells in the pancreas of dox-treated mice, I continued to observe ADM and the 
absence of A→β conversion. Thus, while I do not fully exclude the possibility that Rag1 might 
influence reprogramming efficiency, this variable alone was unable to account for the divergent 
reprogramming outcome when I used 2.0 mg/ml dox to induce 3TF expression. This finding is 
consistent with a recent report showing that acinar cells take on a sustained duct-like appearance 
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thereby impairing pancreatic regeneration in Rag1-/- mice (Folias, Penaranda, Su, Bluestone, & 
Hebrok, 2014). 
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CHAPTER 6 
 
ATTENUATING INFLAMMATION PROMOTES ACINAR TO BETA CELL 
REPROGRAMMING 
 
Introduction 
The original goal of this study was to explore how the combined expression of MafA, 
Pdx1, and Neurog3 causes A→β reprogramming using a transgene-based system. However, I 
found that transgene-mediated expression of these three factors in pancreatic acinar, in marked 
contrast to prior studies using adenoviruses, did not result in the production of new, insulin-
secreting cells but instead causes a potent inflammatory response and the generation of 
pancreatic duct-like cells. This observation led me to explore some of the variables that may 
differ between viral and transgene-based expression of 3TF. Indeed, widespread metaplastic 
changes resulting from tissue inflammation have not been reported when adenoviruses are used 
to introduce the reprogramming factors. I speculate that under normoglycemic conditions similar 
metaplastic conversions are not observed due to the lower infection efficiency of the adenovirus. 
This results in fewer 3TF-expressing cells, thereby lowering the overall inflammatory potential. 
In addition, adenoviral delivery may result in lower levels of 3TF-expression compared to 
transgene-mediated expression, which may also prevent acinar cell damage and pancreatic 
inflammation. Thus, I hypothesized that reprogramming-induced inflammation causes ADM 
thereby preventing A→β reprogramming. I used two approaches to attenuate inflammation. 
First, I lowered the level of dox, reasoning that the robust expression of 3TF was principally 
responsible for the inflammatory response. Second, I used the macrophage toxin gadolinium 
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chloride (GdCl3) to attenuate inflammation during 3TF-medieated reprogramming. I found that 
successful transcription-mediated reprogramming of acinar cells into beta-like-cells can be 
disrupted by both inappropriate levels of the reprogramming factors and pancreatic 
inflammation. Too high factor expression causes pancreatic inflammation and ADM diverting 
the acinar cell to a duct-like cell while too low factor expression does not induce transcriptional 
changes. In this chapter, I discuss my studies investigating the role of inflammation on the 
outcome of A→β reprogramming.    
 
Pancreatic inflammation and ADM 
Damaged pancreatic acinar cells release pro-inflammatory signals that lead to 
macrophage infiltration and activation (Forsmark, 2013). These recruited macrophages can 
induce pancreatic acinar cells to either undergo apoptotic or necrotic cell death, or, if the cells 
survive, ADM (Liou & Storz, 2015).  The precise mechanisms mediating ADM are still under 
investigation. Recently, it has also been shown that M1-polarized macrophages are responsible 
for initiating and driving ADM, and that this metaplastic conversion is mediated through 
macrophage-secreted cytokines such as tumor necrosis factor and chemokines such as 
CCL5/RANTES, which activate NFκB (Liou et al., 2013).  It has also been shown that both the 
EGF receptor ligand TGF-α and activating Kras mutations promote ADM (De La et al., 2008; 
Means et al., 2005; Miyamoto et al., 2003). ADM has also been associated with the activation of 
both Notch and STAT3 signaling pathways (Corcoran et al., 2011; Liou et al., 2015).  Indeed, 
both pathways are upregulated in PDAC, so it is not surprising that these pathways have been 
found to drive ADM. In addition, both pathways are important in establishing cell fates. Notch 
signaling regulates multiple cell fate decisions during pancreatic development and maintains a 
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pool of undifferentiated, progenitor-like cells (Murtaugh, Stanger, Kwan, & Melton, 2003) while 
STAT3 is important in regulating embryonic cell fate (H. Chen et al., 2015).  Moreover, Notch 
signaling, by inducing expression of the downstream transcription factor Hes1, has been shown 
to promote duct cell over endocrine cell commitment during development (Shih et al., 2012). 
Furthermore, Protein Kinase D1 has been shown to act downstream of TGF-β and Kras and to 
induce Notch signaling (Liou et al., 2015) and thus suggested to be involved in mediating ADM. 
   
Pancreatic macrophages  
Macrophages are a highly versatile cell type with a diverse range of functions important 
for tissue homeostasis and injury responses. These diverse biological activities are mediated by 
the phenotypically distinct subpopulations of macrophages that develop in response to 
inflammatory mediators they encounter in their microenvironment (Murray & Wynn, 2011).  
Macrophage subsets differ in their receptor expression, effector function, and cytokine and 
chemokine production (Murray & Wynn, 2011). To date, the two major populations 
characterized are the so-called classically-activated M1 macrophages and the alternatively-
activated M2 macrophages. M1 macrophages secrete pro-inflammatory cytokines and have 
antimicrobial functions whereas M2 macrophages are anti-inflammatory and contribute to tissue 
remodeling and repair (Sica & Mantovani, 2012).  
Little is known about the specific role of activated macrophages in pancreatic 
inflammation except that these cells secrete potent immune system modulators that regulate 
tissue remodeling in order to maintain organ-wide homeostasis. However, their role during 
pancreas development is better defined. During development, F4/80+ macrophages are found in 
the pancreas where they contribute to expansion of the endocrine cell mass with macrophage-
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deficient mice displaying a reduced beta cell mass, abnormal postnatal islet morphogenesis, and 
impaired pancreatic cell proliferation (Banaei-Bouchareb et al., 2004).  After birth, the number 
of F4/80+ macrophages decreases, with adult pancreatic resident macrophages characterized by a 
mixed macrophage profile with the majority being F4/80 negative (Geutskens, Otonkoski, 
Pulkkinen, Drexhage, & Leenen, 2005). 
Pancreatic macrophages are best known for their pathogenic roles in the progression of 
T1 and T2 diabetes, and for this reason, are generally thought to be detrimental for pancreatic 
beta cell survival and function (Tesch, 2007; Yoon & Jun, 2005).  However, pancreatic 
macrophages have also been shown to protect beta cells during pancreatic inflammation, and 
have been implicated in beta cell repair and regeneration in mouse models of pancreatitis 
(Brissova et al., 2014; Tessem et al., 2008; Van Gassen et al., 2015; Xiao et al., 2014) 
 
Results 
	
Reducing the level of 3TF expression lowers the coinciding immune response promoting 
A→β  reprogramming 
Given that pancreatic inflammation was associated with transgenic expression of 3TF, I 
explored the effect of varying 3TF expression by treating the diallelic mice with a 10- and 100-
fold lower concentration of dox for 7 days. I reasoned that robust 3TF expression may be 
responsible for acinar cell damage and the subsequent ADM, thereby preventing successful 
A→β reprogramming. Both groups (mice treated with a 10- and 100-fold lower concentration of 
dox) exhibited lower levels of mCherry fluorescence, consistent with 3TF expression also being 
reduced (Figure 6.1A, C). I also observed that fewer acinar cells expressed mCherry as the 
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concentration of dox was lowered. Indeed, when I used a 10-fold lower concentration of dox to 
induced 3TF expression, there was over a 60% reduction in the number of acinar cells expressing 
3TF after 1 day of dox administration  (78 + 2.5% vs. 30 + 9.9%; n=3). In addition, after 7 days 
of dox treatment, the pancreas in both groups was nearly normal in size (Figure 6.1A), CD45 
staining was reduced (Figure 6.1B, D), and cytokeratin staining was either reduced or absent 
(Figure 6.2A, B). Most importantly, mice treated with the 10-fold lower concentration of dox 
(0.2 mg/ml) exhibited many mCherry+ cells that co-expressed low levels of insulin (Figure 6.2C, 
D). On the other hand, mice given the lowest concentration of dox (0.02 mg/ml) had no 
mCherry+/ insulin+ co-expressing cells nor any mCherry+ cells that co-expressed chromogranin 
A or ghrelin (Figure 6.3A-D). Instead, the mCherry+ cells in these animals continued to express 
amylase at 7 days (Figure 6.3E, F), indicating that they had undergone very little, if any, 
A→β reprogramming within the one-week experimental timeframe. Taken together, these 
findings indicate that A→β reprogramming depends on the level of 3TF expression. When it is 
too low, no reprogramming occurs. Conversely, when it is too high, a potent inflammatory 
response occurs which diverts the reprogramming outcome to an ADM-like phenotype. 
 
Macrophage depletion permits A→β  reprogramming 
I next sought to determine whether the inflammatory response itself might be responsible 
for the divergent reprogramming outcome. Since the majority of immune cells present after 7 
days of 3TF expression were macrophages and since macrophages are involved in mediating 
ADM (Liou et al., 2013), I administered GdCl3, a macrophage toxin (Jankov et al., 2001), both 
prior to and during dox treatment. The depletion of macrophages in the pancreas was confirmed 
by immunostaining for F4/80 (Figure 6.4A, B). Strikingly, the pancreata of mice treated with 
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GdCl3 were nearly normal in both size and appearance (Figure 6.4C, D). Animals administered 
GdCl3 did not exhibit either the formation of tubular complexes or the diffuse cytokeratin-
staining that characterized the diallelic mice not administered GdCl3 (Figure 6.4E, F and 
6.5A,B) nor did they exhibit fibrosis (Figure 6.5C). More importantly, approximately 6% of the 
mCherry+ cells, after 7 days of dox treatment, were found to co-express insulin (Figure 6.6A, B). 
Cell counting after 7 days of treatment revealed approximately 650,000 new beta-like cells per 
animal (Table 6.1). Interestingly cell counting also revealed a decrease in the number of cells 
expressing mCherry at 7 days of dox. 
To further confirm that macrophage depletion promotes 3TF-mediated A→β 
reprogramming, RT-qPCR was performed on FACS-sorted mCherry+ cells. Indeed, both Ins1 
and Ins2 mRNA were increased after 7 days of dox in mice administered GdCl3 (Figure 6.6C). 
These findings suggest that the overly robust expression of 3TF triggers a potent inflammatory 
response, mediated by macrophages, that prevents A→β reprogramming. 
To assess the function of the newly generated beta-like cells, mice were rendered diabetic 
by administration of the beta cell toxin streptozotocin (STZ), treated with GdCl3 to attenuate 
inflammation, then robust 3TF expression was induced with 2.0 mg/ml dox. Within two days, the 
diabetic mice began to exhibit an improvement in blood glucose concentration, and at 6 days, 
their blood glucose concentrations were indistinguishable from untreated control animals 
(Figure 6.7A). Furthermore, by day 7 of dox, two mice died with low blood glucose levels (86 
and 72 mg/dl). Removal of dox at day 7 was followed immediately by a worsening of glycemic 
control and reversion to a fully diabetic state within a few days. Interestingly, intraperitoneal 
glucose tolerance tests (GTT) performed after 7 days of dox treatment revealed two different 
patterns of response in the five mice treated. Two mice appeared to be glucose responsive 
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whereas the other three mice, which were hypoglycemic at the beginning of GTT, lacked 
glucose-sensitive insulin secrection (Figure 6.7B). In any case, these findings indicate a 
sufficient number of new beta-like cells were produced to rescue STZ-induced diabetes and that 
the production of insulin by these cells was dox-dependent. In addition, these results suggest the 
presence of at least two different groups of reprogrammed beta cells, one group that is glucose 
responsive and a second that may constitutively secrete insulin in a non-glucose responsive 
manner. 
Finally, I sought to determine whether I could increase the efficiency of 3TF-mediated 
A→β reprogramming by simultaneously lowering the level of dox and reducing inflammation by 
depleting macrophages with GdCl3. Interestingly, while the dual treatment preserved pancreatic 
mass and histology (Figure 6.8A-C), prevented abnormal cytokeratin staining (Figure 6.8D-F), 
and further decreased tissue inflammation (Figure 6.8G-I), it did not increase the 
reprogramming efficiency (Figure 6.6 D, E). 
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Table 6.1 Estimated number of new beta-like cells produced  
 
Estimated number of new beta-like cells 
Cells in Pancreas 1 57.5 x 106 
mCherry+ Cells* 10.9 x 106 
New beta-like cells** 6.5 x 105 
1 See Ref (Dore et al., 1981)   
*19% of the cells present in the pancreas after 7 days of dox treatment (2 mg/ml) 
are mCherry+  
** 6% of the mCherry+ cells express insulin after 7 days of dox (2 mg/ml) 
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Figure 6.1 Reducing 3TF expression attenuates inflammation. (A) mCherry fluorescence in 
the pancreas of 3TF mice administered either 0.02, 0.2, or 2.0 mg/ml of dox for 7 days. (B) 
Pancreatic immunofluorescence CD45 staining of 3TF mice administered varying concentrations 
of dox at 7 days.  (C) Quantification of fluorescence intensity per pancreas area. Data are 
represented as mean + SEM. *p < 0.05, student’s t-test. (D) Percentage of CD45+ cells among 
DAPI+ cells. Three mice per time point and over 1,000 DAPI+ cells counted for each mouse. Data 
are represented as mean + SEM. *p < 0.05 , student’s t-test 
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Figure 6.2 Reducing 3TF expression attenuates inflammation and promotes A→β  
reprogramming. (A) Immunostaining for PanCK in pancreata of 3TF mice administered varying 
concentrations of dox for 7 days. (B) Percentage of PanCK+ cells among mCherry+ cells. Three 
mice per time point and over 500 mCherry+ cells counted for each mouse. Data are represented as 
mean + SEM. (C) Pancreatic immunofluorescence insulin staining of 3TF mice administered 0.2 
mg/ml of dox for 7 days. mCherry+ cells that co-expressed insulin (arrows) were observed. (D) 
Percentage of insulin+ cells among mCherry+ cells. Three mice per time point and over 500 
mCherry+ cells counted for each mouse. Data are represented as mean + SEM. 
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Figure 6.3 The magnitude of 3TF expression affects the reprogramming outcome. (A) 
Immunostaining for chromogranin A in pancreata of 3TF mice administered varying 
concentrations of dox for 7 days. (B) Percentage of chromogranin A+ cells among mCherry+ cells. 
Three mice per time point and over 500 mCherry+ cells counted for each mouse. Data are 
represented as mean + SEM. (C) Immunostaining for ghrelin in pancreata of 3TF mice 
administered varying concentrations of dox for 7 days. (D) Percentage of ghrelin+ cells among 
mCherry+ cells. Three mice per time point and over 500 mCherry+ cells counted for each mouse. 
Data are represented as mean + SEM. (E) Pancreatic immunofluorescence staining of amylase in 
pancreata of 3TF mice administered varying concentrations of dox for 7 days. (F) Percentage of 
amylase+ cells among mCherry+ cells. Three mice per time point and over 500 mCherry+ cells 
counted for each mouse. Data are represented as mean + SEM. 
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Figure 6.4 Macrophage depletion preserves pancreatic mass and architecture. (A) Pancreatic 
immunofluorescence F4/80 staining of 3TF mice administered either saline or GdCl3 after 7 days 
dox. Arrows indicate F4/80+ cells. (B) Percentage of F4/80+ cells among DAPI+ cells at 7 days 
dox. Three mice per time point and over 1,000 DAPI+ cells counted for each mouse. Data are 
represented as mean + SEM. **p < 0.001, student’s t-test. (C) Representative pancreata from 3TF 
mice given either saline or GdCl3 after 7 days dox. (D) Pancreatic weight per body weight of 3TF 
mice given either saline or GdCl3 and WT mice given GdCl3 after 7 days dox. Data are 
represented as mean + SEM. **p < 0.001, student’s t-test. (E) Pancreatic immunofluorescence 
staining of PanCK of 3TF mice administered either saline or GdCl3 at 7 days dox. (F) Percentage 
of PanCK+ cells among mCherry+ cells at 7 days dox. Three mice per time point and over 500 
mCherry+ cells counted for each mouse. Data are represented as mean + SEM. **p < 0.001, 
student’s t-test.  
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Figure 6.5 Macrophage depletion prevents ADM. (A) Representative pancreatic PanCK 
staining of 3TF mice administered either saline or GdCl3 and WT mice administered GdCl3 at 7 
days dox. (B) Representative H&E staining of 3TF mice administered either saline or GdCl3 and 
WT mice administered GdCl3 at 7 days dox. Tubular complexes (inset) observed in pancreas of 
3TF mice administered saline. (C) Representative Masson’s trichrome stain of 3TF mice 
administered either saline or GdCl3 and WT mice administered GdCl3 at 7 days dox. 
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Figure 6.6 Macrophage depletion promotes A→β  reprogramming. (A) Pancreatic 
immunofluorescence insulin staining of 3TF mice administered GdCl3 at 7 days dox. (B) 
Percentage of Insulin+ cells among mCherry+ cells at 7 days of dox. Three mice per time point 
and over 1,000 mCherry+ cells counted. Data are represented as mean + SEM. (C) RT-qPCR 
analysis of Ins1 and Ins2 expression in 3TF mice given either GdCl3 after 7 days of dox. Fold 
change calculated against mRNA expression in uninduced acinar cells. Data are represented as 
mean + SEM. (D) After 7 days of dox, a few scattered insulin+ cells that expressed mCherry were 
observed. (E) Percentage of insulin+ cells among mCherry+ cells. Three mice per time point and 
over 1,000 mCherry+ cells counted. Data are represented as mean + SEM.  
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Figure 6.7 New beta cells rescue STZ-induced diabetes. (A) Mice were administered STZ on 
day 0 to induce diabetes and dox was administered for 7 days (day 6-13). Blood glucose was 
measured every other day. ● 3TF mice administered GdCl3, STZ, and dox; ■ 3TF mice given 
STZ and dox but not administered GdCl3; ▲WT mice administered GdCl3, STZ, and dox 
(control); ♦ 3TF mice administered GdCl3 and dox but not STZ (control). Significance calculated 
against 3TF mice not given GdCl3. (B) GTT was performed on day 13. (C) Two groups of 
reprogrammed beta cells observed: glucose responsive (n=2) and non-glucose responsive (n=3).  
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Figure 6.8. Simultaneously lowering the concentration of dox and depleting macrophages 
does not further increase A!β  reprogramming. 3TF mice were simultaneously administered 
a low concentration of dox (0.2 mg/ml) and injected with the macrophage toxin GdCl3 for 7 days. 
(A) Representative H&E staining and (B) pancreata from mice reveals that this dual treatment 
preserves pancreas histology and mass. (C) Pancreatic weight per body weight. Data are 
represented as mean + SEM, n=3. (D) Pancreatic PanCK staining and (E) immunofluorescence 
staining of PanCK reveals that this dual treatment prevents ADM. (F) Percentage of PanCK+ cells 
among mCherry+ cells at 7 days of dox. Three mice per time point and over 500 mCherry+ cells 
counted per mouse. Data are represented as mean + SEM. (G) Representative Masson’s trichrome 
stain and (H) immunofluorescence staining of F4/80 reveals that this dual treatment reduces 
inflammation. (I) Percentage of F4/80+ cells among DAPI+ cells.  Three mice per time point and 
over 1,000 DAPI+ cells counted. Data are represented as mean + SEM.  
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Discussion 
By analyzing a novel diallelic transgenic mouse model that expresses 3TF in both a 
pancreatic acinar- and dox-dependent manner, I found that the overly robust expression of 3TF 
in acinar cells does not result in new beta-like cells, but instead causes their conversion into duct-
like cells. This finding led me to discover that the magnitude of transcription factor expression as 
well as tissue inflammation greatly affects the reprogramming outcome. Indeed, only when the 
expression of 3TF or the resulting inflammatory response was attenuated did I observe the 
production of new beta-like cells from pre-existing acinar cells.   
My results suggest that when the concentration of 3TF is too high, pancreatic acinar cell 
stress and damage occurs which causes cytokine release, macrophage infiltration, and ADM, 
thereby preventing A→β reprogramming. I suggest that efficient A→β reprogramming requires 
a coordinated series of events whereby acinar cells cease zymogen production, delaminate and 
migrate to the surrounding mesenchyme, then cluster into new vascularized islets. For these 
many cellular changes to occur without inducing necrosis, acinar cells may need time to cease 
the production and secretion of tissue-digesting enzymes or time to establish a new endocrine 
cell-like state of internal homeostasis. The pace of such events may be directly influenced by the 
concentration of the reprogramming factors with high 3TF expression causing reprogramming to 
occur at a rate that exceeds the ability of the cell to undergo an orderly transition from one cell 
state (acinar) to another (endocrine), leading to cellular damage. Indeed, when I reduced the level 
of 3TF expression, not only did this diminish the inflammatory response but it also resulted in 
the production of new beta-like cells. Such a conclusion is consistent with previous studies that 
have shown the importance of factor level in achieving successful reprogramming (Carey et al., 
2011; Tonge et al., 2014).  
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I also found that inflammation, in particular macrophages, plays a major role in 
determining the success of 3TF-mediated A→β reprogramming. By using GdCl3 to deplete 
macrophages, I was able to blunt the inflammation induced by 3TF expression and prevent 
ADM, thereby enabling the acinar cells to be reprogrammed into beta-like cells. However, the 
mechanisms whereby macrophages are able to block A→β reprogramming are unclear. It has 
been reported that macrophage-secreted cytokines mediate ADM through activation of NFκB 
and STAT3 (Liou et al., 2013). Thus, it is possible that NFκB or STAT3 alter signaling pathways 
that are necessary for A→β reprogramming. Given that STAT3 signaling was recently shown to 
be required for cytokine-mediated A→β conversion (Baeyens et al., 2013), it is possible that 
NFκB signaling plays a very different role, inhibiting A→β  reprogramming by the induction of 
ADM. Inspection of my RNA-seq data revealed an increase in many NFκB targets after 7 days 
of robust 3TF-transgene expression (data not shown), further supporting the role of NFκB 
signaling in mediating AMD and thereby enabling successful A→β reprogramming. Not only is 
NFκB implicated in ADM (Liou et al., 2013), it is also markedly increased in the early 
pathogenesis of pancreatitis and pharmacological inhibition of NFκB results in an amelioration 
of the disease. Indeed, activated NFκB induces the transcription of many genes involved in 
inflammatory and apoptotic responses including cytokines, chemokines, immune receptors, and 
adhesion molecules (H. Huang et al., 2013).   
Furthermore, I estimate that approximately 650,000 new beta-like cells are produced, on 
average, in response to administration of 2.0 mg/ml dox and GdCl3. While this number of cells is 
about a third of the approximately 2 million beta cells in an average mouse pancreas (Dor et al., 
2004), it is sufficient to transiently rescue STZ-induced diabetes. However, the ability of these 
new beta-like cells to stably secrete insulin in a glucose-dependent manner is not established 
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after only 6 days of 3TF treatment since the removal of dox at 7 days caused a quick reversion to 
a diabetic state. These findings are consistent with prior studies that used adenoviral delivery of 
the same three transcription factors in which two months were required for the reprogrammed 
acinar cells to adopt a DNA methylation and transcriptional profile similar to that of endogenous 
beta cells (W. Li, C. Cavelti-Weder, et al., 2014). Thus, my findings support the notion that an 
extended exposure to the three reprogramming factors is necessary for acinar cells to adopt both 
the epigenetic and transcriptional profile of an endogenous beta cell.  
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CHAPTER 7 
 
NOVEL MOUSE MODELS FOR THE TETRACYCLINE-DEPENDENT EXPRESSION OF 
PDX1 AND NEUROG3 
 
Introduction 
In 2008, Zhou et al. reported that forced expression of Pdx1, Neurog3, and MafA, using 
adenoviruses, converts pancreatic acinar cells into new beta-like cells (Zhou et al., 2008). In 
order to determine the specific roles of Neurog3 and Pdx1 in the reprogramming process, the 
Magnuson lab developed tetracycline-inducible mouse models in which the expression of the 
single factors could be specifically induced in pancreatic acinar cells. A recent study, using 
adenoviruses, has begun to tease out the specific role of each of the three factors during 
A→β reprogramming. This study showed that co-infection of mouse pancreas with two different 
adenoviruses carrying Neurog3 and MafA converts pancreatic acinar cells into both glucagon- 
and somatostatin-expressing cells and that infection of mouse pancreas with Neurog3 alone 
converts acinar cells into only somatostatin-expressing cells. Surprisingly, Mafa or Pdx1 alone 
did not induce the formation of any hormone positive cells. These studies suggested that 
Neurog3 is responsible for establishing the genetic endocrine state in acinar cells at the onset of 
reprogramming by suppressing acinar fate-regulators and activating endocrine genes and that 
Mafa and Neurog3 work together to suppress delta cell-specification ensuring the formation of 
beta-like cells (W. Li, M. Nakanishi, et al., 2014). Preliminary studies utilizing my mouse 
models have shown that transgene-mediated expression of Neurog3 causes pancreatic 
inflammation and, similarly, transgene-mediated expression of Pdx1 also results in pancreatic 
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inflammation, a finding that corroborates a report by Miyatsuka et al. showing that transgene-
mediated, expression of Pdx1, in pancreatic cells, causes pancreatic inflammation and ADM 
(Miyatsuka et al., 2006).  
In this chapter, I discuss the derivation and preliminary validation of mouse models that 
express either Neurog3 or Pdx1 and my preliminary findings using these mouse models.   
 
The reprogramming factors 
Pdx1, Neurog3, and MafA, which in combination reprogram acinar cells into new beta-
like cells (Zhou et al., 2008), all play critical roles in beta cell development and function. Pdx1, a 
homeodomain transcription factor, is required for the embryonic development of the pancreas 
and beta cell function with homozygous deletion of Pdx1 resulting in pancreatic agenesis 
(Offield et al., 1996).  Pdx1 is first detected at embryonic day 8.5 in dorsal and ventral buds of 
the foregut endoderm (Guz et al., 1995). The Pdx1-expressing epithelium gives rise to all three 
lineages of the pancreas (acinar, endocrine and duct) (Gu et al., 2003). Pdx1 is required both for 
the primary transition of the pancreas, a phase involving the branching and expansion of the 
developing pancreatic epithelium, and the secondary transition, a period of rapid exocrine and 
endocrine differentiation (Hale et al., 2005). Its expression eventually becomes restricted to beta 
cells where it plays a key functional role. Although Pdx1 haploinsufficient mice develop 
normally, beta cell function is compromised resulting in impaired glucose tolerance and glucose-
stimulated insulin secretion (Brissova et al., 2002). Indeed, Pdx1 activates insulin as well as 
many genes involved in insulin biosynthesis and secretion (Khoo et al., 2012). 
Neurog3, a basic helix-loop-helix transcription factor, is required for Pdx1-expressing 
pancreatic MPCs to enter the endocrine lineage and Neurog3+ cells contribute to all endocrine 
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cells of the mature pancreas (Gradwohl et al., 2000; Gu et al., 2002). Mice carrying a targeted 
disruption of Neurog3 fail to generate pancreatic endocrine cells and die 1–3 days postnatally 
(Gradwohl et al., 2000). Furthermore, forced expression of Neurog3 is sufficient to drive 
precursor cells to an endocrine fate (Apelqvist et al., 1999). In addition, direct targets of Neurog3 
include genes critical for endocrine differentiation such as NeuroD1, Pax4, Insm1,and Nkx2.2 
(H. P. Huang et al., 2000; Smith et al., 2003; Watada et al., 2003).  
While MafA has no known role in beta cell development, it is vital for beta cell 
maturation and function. Beta cell development is unaffected in MafA-deficient mice. However, 
as these mice age, they display glucose intolerance and develop diabetes (C. Zhang et al., 2005). 
Furthermore, MafA is crucial for the functional maturation process as nascent beta cells acquire 
glucose-responsive insulin secretion (Aguayo-Mazzucato et al., 2011). Indeed, direct targets of 
MafA include genes critical for beta cell function, including glucose sensing, vesicle maturation, 
and Ca2+ signaling (H. Wang et al., 2007).  
 
Results 
	
Design and validation of mouse alleles 
 To investigate the specifics role of two individual factors, Neurog3 and Pdx1, in 
A→β reprogramming, the Magnuson lab developed two alleles (Rosa26Neurog3.CFP and 
Rosa26Pdx1.YPF) that after interbreeding with Ptf1artTA allow for the tetracycline-dependent 
expression of either Neurog3 or Pdx1 in pancreatic acinar cells (Figure 7.1A). When adult mice 
containing both the Ptf1artTA and Rosa26Neurog3.CFP alleles were given 2.0 mg/ml dox in their 
drinking water for 1 day, CFP was observed in the pancreas but no other visceral organs, and 
CFP was observed only in the pancreatic acinar cells (Figure 7.2A). Similarly, treatment of 
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Ptf1artTA/+; Rosa26Pdx1.YFP/+ mice with 2.0 mg/ml dox for 1 day resulted in the expression of YFP 
in the pancreas but no other visceral organs, and YFP was observed only in the pancreatic acinar 
cells (Figure 7.2B).  
In order to determine the transcriptional changes associated with single factor 
overexpression, RNA-seq was performed on FACS-purified CFP+ cells from 
Ptf1artTA/+;Rosa26Neurog3.CFP/+ mice and FACS-purified YFP+ cells from 
Ptf1artTA/+;Rosa26Pdx1.YFP/+ mice after 1 and 7 days of dox. Furthermore, to determine if the 
overexpression of either Neurog3 or Pdx1 causes pancreatic inflammation, as is seen with 3TF 
overexpression, I stained pancreata for inflammatory cells using CD45, a pan-leukocyte marker. 
Interestingly, I observed a potent immune infiltration in response to either Neurog3 or Pdx1 
overexpression (Figure 7.3). 
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Figure 7.1 Design of mouse alleles for the dox-dependent expression of either Neurog3 or 
Pdx1 in pancreatic acinar cells. (A) Rosa26Neurog3.CFP and Rosa26Pdx1.YFPalleles were generated 
by recombinase-mediated cassette exchange. When either allele is interbred with Ptf1artTA, the 
two alleles resulted in dox-inducible expression of either Neurog3 or Pdx1 in a pancreatic acinar 
cell-specific manner.  
 
 
 
 
 
	
		
	
91	
  
Figure 7.2 Validation of mouse alleles for the dox-dependent expression of either Neurog3 
or Pdx1 in pancreatic acinar cells. (A) CFP expression was visible after administering 2.0 
mg/ml of dox for 1 day (n=5) to Ptf1artTA; Rosa26Neurog3.CFP mice. CFP fluorescence was restricted 
to the pancreas of dox treated mice and was not observed in other tissues. (B) Dox-inducible, 
acinar cell-specific expression of CFP was confirmed with immunofluorescence analysis. 
Pancreas sections stained with insulin and CFP showed that the two proteins were not co-
localized. (C) YFP expression was visible after administering 2.0 mg/ml of dox for 1 day (n=4) to 
Ptf1artTA; Rosa26Pdx1.YFP mice. YYFP fluorescence was restricted to the pancreas of dox treated 
mice and was not observed in other tissues. (B) Dox-inducible, acinar cell-specific expression of 
YFP was confirmed with immunofluorescence analysis. Pancreas sections stained with insulin 
and YFP showed that the two proteins were not co-localized. 
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 Figure 7.3 Single factor overexpression causes pancreatic inflammation. Pancreatic 
immunofluorescence staining of CD45, fluorescent protein (FP), and DAPI from mice that 
overexpress either Neurog3 (Ngn3) or Pdx1 in the pancreatic acinar cells after 1, 7, and 28 days 
of dox.  
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Discussion 
In order to determine the specific roles of Neurog3 and Pdx1 in the 3TF-mediated 
reprogramming of acinar cells into insulin-secreting beta-like cells, the Magnuson lab developed 
tetracycline-inducible mouse models in which the expression of the single factors could be 
expressed specifically in pancreatic acinar cells. While adenoviral-mediated delivery of Neurog3 
has been shown to convert acinar cells into somatostatin-expressing cells and adenoviral-
mediated delivery of Pdx1 did not induce the formation of any hormone positive cells (W. Li, M. 
Nakanishi, et al., 2014), my studies showed that transgene-mediated delivery of either Neurog3 
or Pdx1 resulted in pancreatic inflammation and ADM. 
My previous findings, discussed in Chapter 4, showed that high levels of 3TF-transgene 
expression induced by 2.0 mg/ml of dox causes acinar cell necrosis resulting in marked 
inflammation and ADM. Only when inflammation is attenuated, either by reducing the intensity 
of 3TF expression or by depleting macrophages, did the production of new beta-like cells occur. 
Thus, it is possible that the high levels of either Pdx1 or Neurog3 expression alone also cause 
acinar cell stress and necrosis, which triggers a potent inflammatory response and ADM thereby 
masking their reprogramming potential. To truly investigate the role of the single factors, it may 
also be necessary to attenuate the inflammatory response.  
Nonetheless, inflammation of the pancreas confers signifigant risk for PDAC (Siegel et 
al., 2013). However, the signaling mechanisms underlying ADM are largely undefined. My 
mouse models, which all result in a potent inflammatory response and ADM, could potentially 
allow us to elucidate the mechanisms underlying ADM.  
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CHAPTER 8 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
Diabetes is a global epidemic affecting over 350 million individuals worldwide. 
Among the two most prevalent types, T1D is characterized by the autoimmune destruction of 
beta cells and T2D arises from either insufficient insulin synthesis or insulin resistance 
leading to hyperglycemia. Currently the most effective treatment for T1D has been lifelong 
insulin therapy. While, transplantation of whole pancreas and isolated beta cells have proven 
effective (Shapiro et al., 2006) the shortage of cadaver pancreases, have lent strong motivation to 
the search for new sources of beta cells. A promising strategy to produce beta cells is the 
reprogramming of other terminally differentiated cells into beta cells (Bonner-Weir & Weir, 
2005; Pagliuca & Melton, 2013).  
Studies over the past decade have established that the identity of pancreatic cells is 
much less firmly fixed than once thought, and that cells within this organ can undergo specific 
fate conversions in response to pancreatic ductal ligation (Pan et al., 2013), cytokine treatment 
(Baeyens et al., 2013), severe hyperglycemia (Thorel et al., 2010), and expression of 
transcription factors (Zhou et al., 2008). These discoveries have stimulated interest in learning 
more about specific reprogramming events in order to understand their biological nature, and to 
be able to exploit these natural processes to generate new pancreatic beta-like cells from other 
non-beta cell types. Such knowledge, if adequately understood and developed, may enable the 
physiological regeneration of beta cells in patients with T1D (Bramswig et al., 2013; W. Li, M. 
Nakanishi, et al., 2014; Thorel et al., 2010; Zhou et al., 2008).   
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Of the various pancreatic cell types that might be targeted for reprogramming, acinar 
cells are especially appealing since they are highly abundant, exhibit transcriptional plasticity 
(W. Li, M. Nakanishi, et al., 2014; Puri et al., 2015; Ziv et al., 2013), and are derived from a 
common progenitor cell during pancreatic organogenesis (Gu et al., 2002). Two different 
strategies for the in vivo reprogramming of acinar cells into beta-like cells were recently 
described.  In the first, Zhou et al. used adenoviruses that express three pancreas-specific 
transcription factors (MafA, Pdx1, and Neurog3) to convert pancreatic acinar cells into new 
insulin-secreting cells (Zhou et al., 2008).  In the second, Baeyens et al. showed that transiently 
administered epidermal growth factor and ciliary neurotrophic factor promoted the conversion of 
pancreatic acinar cells into new beta-like cells (Baeyens et al., 2013). However, the precise 
mechanisms enabling or limiting this cellular conversion are not understood.  Indeed, the factors 
and experimental variables that promote, limit, or modify cellular reprogramming in vivo remain 
largely to be defined. In the case of transcription factor mediated reprogramming, some of  the 
variables may include the use of a virus (A. Y. Wang et al., 2007), concentration and 
stoichiometry of the transcription factors (Carey et al., 2011), the presence or absence of an 
inflammatory response (Lee et al., 2012), and hyperglycemia (Cao, Tang, Horb, Li, & Yang, 
2004).  Thus, for an in vivo beta cell restorative therapy to ever become clinically feasible, we 
need a better understanding of the factors that promote or inhibit specific cellular identity 
conversions, and the physiological effects that inducing such conversions might inevitably cause. 
 Using a novel mouse model that expresses 3TF in both a pancreatic acinar cell- and dox-
dependent manner, my thesis work has been focused on studying the factors that modulate acinar 
to beta cell conversion and the physiological effects that such conversion induces. I have 
discovered that the outcome of transcription factor-mediated acinar to beta-like cellular 
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reprogramming is dependent on both the magnitude of 3TF expression and on reprogramming-
induced inflammation. My findings indicate that the overly robust expression of 3TF in acinar 
cells induces pancreatic inflammation which blocks A→β reprogramming and results, instead, in 
the production of new duct-like cells (Figure 8.1). Only when inflammation is attenuated, either 
by reducing the intensity of 3TF expression or by depleting macrophages, does the production of 
new beta-like cells occur. The new beta-like cells were able to reverse streptozotocin-induced 
diabetes 6 days after inducing 3TF expression but failed to sustain their function after removal of 
the reprogramming factors. 
Thus, I propose that when the concentration of 3TF is too high, pancreatic acinar cell 
stress and damage occurs, thereby causing cytokine release, macrophage infiltration, and ADM, 
which prevents A→β reprogramming. I further suggest that efficient reprogramming requires a 
coordinated series of events whereby acinar cells cease zymogen production, delaminate and 
migrate to the surrounding mesenchyme, then cluster into new vascularized islets. For these 
cellular changes to occur without causing cellular damage and inducing inflammation, acinar 
cells may need time to cease the production and secretion of tissue-digesting enzymes before 
delamination from the pancreatic duct.  
The pace at which reprogramming occurs is likely influenced by the concentration of the 
reprogramming factors. If 3TF expression is too high, and reprogramming occurs at a rate that 
exceeds the ability of the cell to undergo an orderly transition from one cell state to another, 
acinar cell damage may occur, preventing the formation of new beta-like cells. Indeed, when I 
reduced the level of 3TF expression, the inflammatory response was attenuated and new beta-
like cells were produced. Conversely, if 3TF levels are too low, no reprogramming occurred, at 
least within a one-week timeframe.  
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I have also found that the presence of inflammatory macrophages within the pancreas 
greatly influences the outcome of 3TF-mediated acinar cell reprogramming. While depleting T- 
and B-cells during reprogramming does not prevent ADM or allow for the production of new 
beta-like cells, the depletion of macrophages, by the administration of GdCl3, prevented ADM, 
thereby enabling the acinar cells to be reprogrammed into beta-like cells. The mechanisms 
involved in the macrophage-dependent blockage of A→β reprogramming remain unclear, but it 
has been reported that macrophage-secreted cytokines mediate ADM through activation of 
NFκB and STAT3 (Liou et al., 2013). While the RNA-Seq data suggest that inflammation 
enhances signaling through NFκB, STAT3 signaling was recently shown to be required for 
cytokine-mediated A→β conversion (Baeyens et al., 2013).  Thus, it is possible that NFκB and 
STAT3 signaling oppose each other, with STAT3 signaling promoting A→β reprogramming and 
NFκB signaling impairing reprogramming by causing ADM.  
Furthermore, I estimate that approximately 650,000 new beta-like cells are produced, on 
average, in response to administration of 2.0 mg/ml dox and GdCl3. While this number of cells is 
about a third of the approximately 2 million beta cells in an average mouse pancreas (Dor et al., 
2004), it is sufficient to transiently rescue STZ-induced diabetes. Furthermore, adenoviral 
delivery of the reprogramming factors has been reported to result in 40-50% of infected acinar 
cells being converted to new beta-like cells (W. Li, C. Cavelti-Weder, et al., 2014). While I 
expected that the transgenic delivery of the factors would further improve reprogramming 
efficiency, I found the opposite with only 6% of 3TF-expressing cells expressing insulin after 7 
days. This suggests that there are additional variables that distinguish adenoviral- and transgene-
mediated reprogramming, such as the dynamics of 3TF-expression. While use of the Tet-On 
system has the distinct advantage of allowing us to simultaneously turn on or off 3TF expression 
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and to vary the amount of 3TF expression, it does not allow stable expression of the 
reprogramming factors over an extended time. My use of the Ptf1a gene to drive expression of 
rtTA, while being a straightforward means of achieving acinar-cell specificity, has the limitation 
that Ptf1a expression is extinguished as acinar cells are converted into new beta cells. This 
limitation can only be overcome with a more complicated transgene design. 
Widespread metaplastic changes resulting from tissue inflammation have not been 
reported when adenoviruses are used to introduce the reprogramming factors into the pancreas of 
normoglycemic mice (Cavelti-Weder et al., 2016). I speculate that similar metaplastic 
conversions are not observed due to the low infection efficiency of the adenovirus, which results 
in fewer acinar cells expressing the reprogramming factors, thereby avoiding triggering 
widespread pancreatic inflammation and allowing for more of the virally-infected cells to be 
reprogrammed. However, despite the highly penetrant expression of 3TF in my transgene-based 
model (nearly 80% of acinar cells at 2.0 mg/ml dox), I could only achieve the visible 
reprogramming of 6% of the 3TF-induced cells. Even so, I was able to produce over twice the 
number of new insulin-positive cells (650,000 versus 245,000 ± 32,000) that were reported when 
using an adenovirus (W. Li, M. Nakanishi, et al., 2014). This very marked difference in 
experimental outcome is likely due to my inability to fully suppress pancreatic inflammation 
when using a high dose of dox to express 3TF in the maximum number of acinar cells.  
My findings indicate that a better understanding of the role of transcription factor 
concentration, duration of expression, and the number of cells affected, will be essential for 
translating findings in mice to humans. However, due to the physiological role of acinar cells, 
whose function is to produce enzymes for the digestion of proteins, complex carbohydrates, 
lipids, and nucleic acids, and thus pose a very real potential for pancreatic autodigestion, much 
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consideration must be taken on the safety and efficacy of employing the acinar cell as a 
reprogramming target. 
In any case, the very marked differences in experimental outcomes compared to those 
achieved using an adenovirus suggest that both the dynamics and secondary effects of A→β 
reprogramming are complex.  However, by exploring the outcomes achieved with a transgene-
based reprogramming model, a better understanding of some of the many variables that will need 
to be understood to be able to safely and efficiently reprogram acinar cells in humans has been 
obtained. 
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Figure 8.1 Model of divergent 3TF reprogramming. Adenoviral delivery of 3TF to the 
pancreatic acinar cells of Rag1-/- mice is relatively inefficient resulting in only a few pancreatic 
acinar cells expressing 3TF. Low levels of inflammation permit A→β reprogramming. Transgene 
expression of 3TF in the pancreatic acinar cells of Rag1+/+ mice is very efficient resulting in 
many acinar cells expressing 3TF and high levels of 3TF expression. Rapid reprogramming 
causes ER stress, a rise in [Ca2+]i, and cell death, triggering a potent inflammatory response that 
results in ADM, thereby blocking A→β reprogramming.  
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Future directions 
 
Why do high levels of 3TF expression lead to pancreatic inflammation and macrophage 
infiltration? 
It is unclear as to why robust expression of 3TF in a large portion of acinar cells causes 
acute pancreatic inflammation. Efficient A→β reprogramming may require a coordinated series 
of events and robust expression of 3TF may disrupt these events, thereby causing pancreatic 
inflammation. Indeed, given that profound transcriptional changes are required for an acinar cell 
to become a beta cell, it is easy to imagine a loss of cellular homeostasis if the transition from 
one cell type to another occurs too rapidly. Moreover, the loss of cellular homeostasis could be 
further compounded by the disruption in tissue morphology, something that might result in the 
inappropriate secretion of proteolytic enzymes within the pancreas itself. It is also possible that a 
high concentration of 3TF causes a pathological increase in the [Ca2+]i in acinar cells, which 
triggers the premature activation of pancreatic zymogens such as trypsinogen, and activation of 
the ER stress response mechanism (Muili et al., 2013; Raraty et al., 1999; Sah et al., 2014). 
Indeed, in acinar cells, a rise in [Ca2+]i  has been associated with ADM and is known to cause 
activation of inflammatory genes and the ER stress response (Sah et al., 2014). Furthermore, 
inspection of the RNA-seq data revealed a marked increase in both the expression of genes 
encoding voltage-gated and other Ca2+ channels and of genes involved in the activation of the 
unfolded protein response after 7 days of robust 3TF-transgene expression. However, future 
studies will need to be conducted to test whether high concentration of 3TF causes a pathological 
increase in the [Ca2+]i in acinar cells.  
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What are the effects that activated macrophages have on signaling pathways in 3TF-
expressing acinar cells?   
My studies show that high levels of 3TF-transgene expression in pancreatic acinar cells 
results in a potent inflammatory response and ADM within 7 days of dox administration at 2.0 
mg/ml. Macrophage infiltration is observed as early as 2 days and persists for up to 28 days.  
Furthermore, I have shown that depletion of macrophages prior to and during 3TF-mediated 
reprogramming attenuates the ADM phenotype and promotes successful A→β reprogramming. 
However, it is not understood how macrophages affect the outcome of A→β reprogramming. 
Indeed, the cytokines secreted or the signaling pathways they activate within 3TF-expressing 
acinar cells, which result in ADM and the prevention of A→β reprogramming is unkown. While 
it has been reported that macrophage-secreted cytokines mediate ADM through activation of 
NFκB signaling (Liou et al., 2013) and inspection of the RNA-seq data revealed an increase in 
many NFκB targets in acinar cells after 7 days of robust 3TF-transgene expression, future studies 
profiling the recruited macrophages to determine their polarization state and use of 
pharmacological approaches to accurately assess the signaling pathways that become activated 
within acinar cells in response to inflammation need to be conducted.  
 
Optimize the efficiency of 3TF-induced A→β  reprogramming  
Two models for the reprogramming of fibroblasts to iPSCs have been proposed. An “elite” 
model posits that only a subset of cells are capable of being reprogrammed whereas a 
“stochastic” model posits that all cells have the potential to be reprogrammed (Yamanaka, 2009).  
Others have suggested that the reprogramming process can also be considered “deterministic” 
with fixed latency periods or “stochastic” with different latency periods (Hanna et al., 2009).  
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Determining the mechanism by which acinar cells are reprogrammed into new beta cells is 
important since, if it occurs by an elite mechanism, efforts should be directed to identifying and 
producing more elite cells. On the other hand, if it is stochastic, attention should be on improving 
the reprogramming protocol. At present, the highest A→β conversion efficiency I have achieved 
is approximately 6% even though mCherry and 3TF are expressed in over 70% of the acinar 
cells. This is considerably less than the 40% reprogramming efficiency reported by Li et al. (W. 
Li, C. Cavelti-Weder, et al., 2014) using an adenoviral vector that simultaneously expresses all 
three reprogramming factors. Since I hypothesize that A→β reprogramming is likely to be a 
stochastic process, and since expression of the 3TF-expressing transgene is highly penetrant, I 
expect to surpass the reported efficiencies when an optimal concentration of 3TF is identified 
and when I am able to fully suppress pancreatic inflammation. Future studies will need to be 
conducted to determine the optimal concentration of factors required for efficient 
reprogramming.  
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